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Abstract 
N-Methyl-D-aspartate (NMDA) receptors are critically involved in 
synaptic transmission, neural development and various forms of neuronal 
plasticity including long-term potentiation (LTP) and long-term depression 
(LTD). They are also involved in the production of neuronal damage 
following excessive activation by glutamate released as a result of hypoxia 
or ischaemia. Each heteromeric receptor includes one or two NRl 
subunits, at least two of the four NR2A-D subunits and less usually the 
NR3AJB subunits. This study demonstrates that the putative NR2B 
subunit-containing NMDA receptor antagonist Ro 25-6981 potentiates the 
effects ofNMDA on rat hippocampal slices. The NR2A subunit antagonist 
PEAQX blocks the effects of NMDA alone and the potentiated response 
following Ro 25-6981 application. Furthermore, Ro 25-6981 was not 
neuroprotective as reported previously but unexpectedly precipitated 
excitotoxicity. The potentiating effect of Ro 25-6981 required around 20 
minutes to become apparent, took a further 30 minutes to reach its 
maximum effect and was irreversible. It was not prevented by 
staurosporine (a broad-spectrum protein kinase inhibitor), okadaic acid (a 
potent inhibitor of the serine/threonine protein phosphatases types 1 and 
2A) or anisomycin (a protein synthesis inhibitor). However, the 
potentiation was prevented by cyclosporin A (an inhibitor of 
Ca2+/calmodulin-dependent phosphatase 2B [calcineurin]). The results 
" :.::2~·,. 
indicate that in an intact neuronal network, NR2B subunits tonically gate 
NR2A subunit-containing receptor function by a negative coupling 
mechanism involving ca1cineurin activation. 
NMDA receptor-dependent LTP induced by high frequency stimulation 
was prevented by PEAQX, an NR2A antagonist. Ro 25-6981 was unable 
to prevent L TP induction but was associated with a marginal reduction in 
the magnitude of LTP induced. 
There is evidence for the binding of homoquinolinic acid to an NMDA-
insensitive novel binding site in the brain. This study investigated the 
pharmacology of homoquinolinate on the evoked field excitatory synaptic 
potential (fEPSP) recorded from the CAl area of rat hippocampal slices. 
Two NMDA receptor agonists, quinolinic acid 150/lM and homoquinolinic 
acid 2.5/lM, caused an approximately 50% inhibition of fEPSP slope. 
Paired-pulse studies suggested there might be a presynaptic component to 
this action that is independent of presynaptic adenosine Al receptor 
activation. The broad-spectrum EAA antagonist kynurenic acid and the 
NMDA receptor blockers 2-amino-5-phosphonopentanoic acid and 
dizocilpine could prevent the inhibition of fEPSP slope. None of these 
antagonists revealed any other NMDA-insensitive activity of 
homoquinolinic acid. The use of 2-carboxy-3-carboxymethylquinoline 
(CCMQ) to displace the reported NMDA-insensitive binding had no effect 
on either baseline fEPSP slope or the depression caused by homoquinolinic 
3 
acid. It was also apparent that responses to homoquinolinic acid were 
blocked completely by the NR2A subunit-selective antagonist PEAQX, but 
not by the NR2B subunit-selective blocker Ro 25-6981. It was concluded 
that the novel binding site for homoquinolinic acid does not affect synaptic 
potentials in the hippocampus and that homoquinolinic acid appears to be a 
selective agonist at NMDA receptors that include the NR2A subunit. 
Although the NR2B agonist site may be maximally activated under normal 
conditions and therefore it is not possible to observe any additional effects 
upon fEPSP slope. 
This study next investigated the negative coupling between NR2B and 
NR2A subunit-containing receptors, combining the NR2A1B subunit 
selective agonist HQA with the NR2B and NR2A selective antagonists 
Ro 25-6981 and PEAQX. The negative coupling observed previously with 
applications of NMDA was also seen using HQA and QA. The 
potentiation of responses to HQA by Ro 25-6981 application was also 
associated with an enhancement of paired-pulse interactions. The 
subsequent application of PEAQX was able to block both the depression of 
fEPSP slope and the associated enhancement of paired-pulse interactions. 
The presence of a presynaptic element during applications of HQA alone 
and potentiated responses alike and the blockade of these effects by 
PEAQX suggests the NR2A subunit-containing NMDA receptor is 
responsible for the presynaptic effects acting either directly at presynaptic 
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sites or indirectly at postsynaptic sites leading to the raising of a retrograde 
signal. The NR2B subunit in both its activated and antagonised state was 
associated with enhancements in paired-pulse interactions which suggest 
that it is not able to modulate directly the presynaptic element. However, 
whilst paired-pulse interactions are generally accepted to he presynaptic 
phenomena, it does not follow that postsynaptic effects cannot influence 
the appearance of changes in these interactions in field recordings. The 
absence of any observable difference between HQA, QA and NMDA 
results suggests that the NR2D subunit is not obviously involved in these 
processes. 
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Chapter 1. Introduction 
NMDA receptor: an historical perspective 
The excitatory amino acid transmitter field has its historical origins in the 
finding of the convulsive effects of L-glutamate and L-aspartate upon 
mammalian brain tissue (Hayashi, 1952; 1954) and their depolarising and 
excitatory effects on central neurones (Curtis, 1959; 1960). However the 
concept that such an amino acid, found in relatively high concentrations in 
the central nervous system (CNS), may be responsible for the majority of 
neurotransmission only became accepted with the accumulation of later 
evidence from electrophysiological, pharmacological and molecular 
biological studies. L-glutamate is now considered the principal excitatory 
neurotransmitter in the mammalian CNS acting upon a variety of receptor 
types. The existence of glutamate receptor subtypes was suggested by the 
observations that glutamate agonist analogues showed different potencies 
on different subsets of neurones (Curtis & Johnston, 1974; McLennan, 
1983). Furthermore, the development of several antagonists in the early 
1970' s that had differential effects upon agonist responses resulted in an 
initial classification ofNMDA, quisqualate and kainate receptors (Evans et 
ai., 1978; Davies & Watkins, 1979; McLennan & Lodge, 1979; Ault et aI., 
1980). Since quisqualate was later shown to activate metabotropic 
glutamate receptors (Sladeczek et ai., 1985; Nicoletti et ai., 1986) and a 
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new agonist, a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
(AMPA) (Krogsgaard Larsen et a/., 1980), was demonstrated to be 
selective for the quisqualate-activated non-NMDA receptors the ionotropic 
receptor family was reclassified as NMDA, AMP A and kainate 
(Collingridge & Lester, 1989). This has since been confirmed with the 
cloning and functional expression of various NMDA, AMP A and kainate 
receptor subunits (Hollmann & Heinemann, 1994). 
NMDA receptor physiology 
The NMDA receptor is a heteromeric ligand-gated ion channel that 
interacts with multiple intracellular proteins by way of different subunits 
(McBain & Mayer, 1994; Husi et ai., 2000). NMDA receptors are 
involved in a variety of neural processes, including long-term potentiation 
(LTP) (Collingridge & Singer, 1990; Bliss & Collingridge, 1993), long-
term depression (LTD) (Dudek & Bear, 1992; Mulkey & Malenka, 1992), 
learning, memory (Olney, 1990; Nakanishi et ai., 1992), brain 
development, excitotoxicity (Choi & Rothman, 1990), neuropathologies 
such as epilepsy, psychosis and neurodegenerative diseases (Choi, 1988; 
Greenamyre & Young, 1989; Meldrum & Garthwaite, 1990; Doble, 1995). 
The NMDA receptor is characterised by a number of unique and important 
properties that distinguishes it from other ligand gated ion-channels. 
Firstly, extracellular Mg2+ at resting membrane potentials blocks the 
24 
NMDA receptor channel and it is only opened with simultaneous 
depolarisation and agonist binding (Mayer et aI., 1984). Secondly, NMDA 
receptor channels are highly permeable to both monovalent cations and 
Ca2+ ions. NMDA receptor activation results in an influx of Ca2+ as well as 
the influx of Na+ and efflux of K+ that is characteristic of all excitatory 
amino acid (EAA) ionotropic receptors (MacDermott et at., 1986; Mayer & 
Westbrook, 1987; Schneggenburger et aI., 1993). This characteristic Ca2+ 
entry is the key trigger for many important physiological phenomenon 
including LTP (Lynch et at., 1983; Bliss & Collingridge, 1993) and LTD 
(Dudek & Bear, 1992; Selig et at., 1995) where the relative magnitude of 
the rise in intracellular Ca2+ concentration and its temporal and spatial 
character determines which plasticity is induced (Lisman, 1989; Artola & 
Singer, 1993; Neveu & Zucker, 1996). Furthermore, prolonged activation 
of NMDA receptors results in excessive Ca2+ influx producing neuronal 
cell death in hypoxia, ischaemia and neurodegenerative disorders (Choi, 
1988). Thirdly, the coincident binding of glutamate and the co-agonist 
glycine is necessary for receptor activation (e.g. two molecules of glycine 
and two molecules of glutamate in a tetrameric, heterodimeric, 
NR11NR11NR21NR2 receptor) (Johnson & Ascher, 1987; Kleckner & 
Dingledine, 1988). Glycine is present in cerebrospinal fluid at a 
concentration of about 10~M (Curtis & Johnston, 1974) and could be 
expected to attain a similar concentration in the extracellular fluid. At 
these concentrations the NMDA receptor could be fully saturated with 
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glycine, however it is conceivable that glycine is also released from glia or 
from the presynaptic terminal as a co-transmitter (Davanger et al., 1994). 
Furthermore, the widespread expression of mRNA for glycine transporter-l 
throughout the brain, with a distribution colocalized to that of the NRI 
subunit suggests that the concentration of glycine is closely regulated 
(Smith et al., 1992). It has been reported by some groups that the 
application of glycine potentiates NMDA receptor-mediated synaptic 
transmission (Danysz et al., 1989; Wilcox et al., 1996; Lim et al., 2004) 
but not by others (Fletcher & Lodge, 1988; Obrenovitch et al., 1997). 
NMDA receptor molecular biology 
Molecular studies have reported that native rat NMDA receptors may be 
either tetrameric or pentameric membrane proteins comprising the NMDA 
receptor 1 (NR1) subunit family, of which there are eight splice variants 
(NRla-h based upon the presence or absence of 3 exons) encoded by a 
single gene, and the NR2 subunit family, of which there are four members 
(NR2A-D) (Laube et al., 1998), each encoded by four distinct genes 
(Seeburg et al., 1994; Dingledine et al., 1999). A third family ofNMDA 
receptor subunits, NR3, has also been described (Ciabarra et al., 1995; 
Sucher et al., 1995); of which there are two types NR3A and NR3B that 
less commonly contribute to NMDA receptors (Nishi et al., 2001; 
Chatterton et al., 2002; Eriksson et al., 2002). The NR3A subunit has been 
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shown to function during early development and to modulate negatively 
ion channel activity (Das et ai., 1998). It has been reported that mutations 
in the NR2 subunit alters the NMDA receptor's response to glutamate 
whilst mutations in the NR1 subunit do not (Laube et ai., 1997; Anson et 
ai., 1998; Anson et ai., 2000). This is consistent with the pronounced 
glutamatergic heterogeneity of the native NMDA receptor being dependant 
upon the NR2A-D subunit complement and the slight heterogeneity seen 
with NR1 splice variants (Buller & Monaghan, 1997). In particular, the 
presence of different NR2A-D subunits within a heteromeric receptor 
confers different degrees of affinity for glutamate and dictates the 
functional properties of the receptor (table2). Thus, the NR2 subunit 
contains the glutamate binding site (Laube et aI., 1997) whilst the co-
agonist glycine's binding site is located on the NR1 and the NR3 subunit 
(Kuryatov et aI., 1994). Native heteromeric receptor complexes are 
thought to be combinations of one or two NR1 and/or NR3 subunits 
forming the glycine-binding site and two or three NR2 subunits providing 
the glutamate-binding site. The exact subunit composition influencing the 
NMDA receptors' pharmacology and function (Kohr & Seeburg, 1996; 
Krupp et ai., 1996; Monaghan & Larsen, 1997; Vicini et ai., 1998; Pizzi et 
ai., 1999). The subunit composition of the NMDA receptor is dynamic, 
changing during synaptic development (Kew et ai., 1998a; Tovar & 
Westbrook, 1999), synaptic plasticity (Kiyama et ai., 1998; Manabe et ai., 
2000) and other physiological and pathophysiological processes. The 
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activity-dependent trafficking of NMDA receptors is achieved both by 
receptors recycling through exocytosis-endocytosis from intracellular sites 
and lateral diffusion of receptors between synaptic and extrasynaptic sites 
(Tovar & Westbrook, 1999; Grosshans et al., 2002; Groc et al., 2004; 
Lavezzari et al., 2004). 
NMDA receptor distribution 
Glutamate receptors are predominantly expressed in the CNS, but have also 
been reported in pancreatic islet cells, osteoclasts, osteoblasts, nerve 
terminals in the skin, mast cells, taste buds, cardiac ganglia and even in 
plant cells. The first evidence for differential NMDA receptor distribution 
came from electrophysiological studies into the endogenous agonist 
quinolinic acid (QA), which demonstrated variable potency in different 
brain regions (Stone & Burton, 1988). In the brain NMDA receptors are 
now known to be heterogeneously distributed according to their subunit 
composition, in particular to that of the NR2 family (Monaghan & Buller, 
1994) (see table 1). The NR1 subunit is expressed throughout the brain 
with little differential distribution of splice variants (Nakanishi et al., 1992; 
Laurie & Seeburg, 1994) The NR2A-D subunits are expressed in a very 
distinct pattern (Watanabe et al., 1993; Buller et a!., 1994; Laurie & 
Seeburg, 1994). In the adult brain the NR1 and NR2A subunits are 
ubiquitous, the NR2B subunit is expressed mainly in the forebrain, NR2C 
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is found particularly in the cerebellum and various select nuclei and NR2D 
expression is limited to the diencephalon and the mid-brain (McBain & 
Mayer, 1994). Hippocampal CAl pyramidal cells express mRNA for NRl, 
NR2A, NR2B and NR2D in the adult human (Scherzer et aI., 1997) and the 
juvenile rat (Kirson et aI., 1999). 
NMDA receptors have been amply demonstrated on the postsynaptic 
membrane (Petralia et aI., 1994; Racca et aI., 2000), and there is 
accumulating evidence suggesting a presynaptic locus. AMP A, mGlu and 
kainate receptors have all been established as presynaptic autoreceptors in 
the hippocampus (Vazquez et aI., 1994; Chittajallu et al., 1996; Alici et al., 
1997), modulating excitatory transmission by altering glutamate release 
probability. Immunohistochemical studies have suggested the existence of 
presynaptic NMDA autoreceptors (Liu et al., 1994; Paquet & Smith, 2000). 
Also, functional studies have reported evidence for presynaptic NMDA 
receptors in the cerebellum (Glitsch & Marty, 1999), visual cortex 
(Sjostrom et al., 2003), spinal cord (Liu et aI., 1997), hippocampus 
(Breukel et aI., 1998), suprachiasmatic nucleus (Hamada et aI., 1998) and 
entorhina1 cortex (Berretta & Jones, 1996). Presynaptic NMDA receptors 
have been reported to be NR2B subunit-containing and tonically activated, 
causing an increase in glutamate release probability, dependent upon Ca2+ 
influx, in the entorhina1 cortex (Woodhall et aI., 2001). 
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NMDA receptor development 
Developmentally only NR2B and NR2D subunits are present and 
widespread in the prenatal brain but shortly after birth, NR2A and NR2C 
subunits quickly predominate while the NR2B and NR2D subunits decline 
to adult levels and a limited distribution. NR2B subunits are expressed 
from late embryonic stages up to adulthood, while expression of NR2A 
subunits only develops during early postnatal stages and rises to mature 
levels by post-natal day 21 (Williams et al., 1993; Mori & Mishina, 1995; 
Wenzel et al., 1995; Portera Cailliau et al., 1996). This transformation is 
particularly significant for the age-dependence of synaptic plasticity (Kemp 
et aI., 2000) and glutamate toxicity (Liu et aI., 1996). NR1 subunits are 
present and widespread both pre- and post-natally (Lynch & Guttmann, 
2001)(see tables 1,2 and 3). 
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Subunit Localisation in adult Developmental 
animals course 
NRI Ubiquitous with splice variant Prenatal and postnatal 
distribution limited to specific 
cells 
NR2A Widespread throughout the Develops post-natally 
forebrain. Less prominent in 
the basal ganglia 
NR2B Largely limited to forebrain Widespread with later decline 
to adult levels and 
distribution 
NR2C Largely limited to cerebellum Appears postnatally 
NR2D Isolated cells of thalamus, sub Widespread prenatally 
thalamus and nNOS 
containing cells of cortex 
Table 1. Summary of the distribution and developmental course of NMDA 
receptor subunits. 
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NMDA receptor Subunit heterogeneity property 
Glutamate and glycine 2D > 28> 2C 
affinity 
Channel open 2A (2-5 fold higher) > 28 probability 
Peak current density 2A (4 times larger) > 28 
Channel conductance 2A, 28 » 2C, 2D 
Receptor kinetics 2A > 28 = 2C > 2D 
Current decay time 2A > 28 > 2C > 2D 
Ca~'" influx 28 >2A 
Sensitivity to Mg~· 2A, 28 » 2C, 2D block 
Deactivation time 2D » 28, 2C > 2A 
Desensitisation 2A » 2D » 28, 2C 
sensitivity 
Speed of recovery from 2A > 2A128 > 28 desensitisation 
Proton sensitivity 2A > 28 > 20 > 2C 
Table 2. Summary of the functional heterogeneity of NMDA receptors 
depending on the presence of specific NR2 subunits. 
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Widely distributed in mammalian CNS (especially 
NMDA 
enriched in hippocampus and cerebral cortex). 
Widespread in CNS; similar distribution to NMDA 
AMPA 
receptors. 
Concentrated in a few specific areas of CNS, 
Kainate 
corresponding to NMDA and AMP A receptor distribution. 
A class of receptors positively linked to inositol 
Metabotropic 
triphosphate or negatively to cyclic AMP formation. 
Table 3. Summary of the general distribution of excitatory amino acid (EEA) 
receptors in the mammalian eNS. 
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NMDA receptor pharmacology 
The complicated physiology of the NMDA receptor complex provides 
agonists and antagonists with several distinct binding sites: glutamate, 
strychnine-insensitive glycine, ion-channel, polyamine and other 
modulatory sites (Figure 1). 
Glutamate, NMDA, aspartate, quinolinic acid, homoquinolinic acid and 
other agonists activate the glutamate site; the prototypic antagonist of this 
site is 2-AP5. The glycine site is activated by glycine (Johnson & Ascher, 
1987) and several antagonists exist including ACBC, CGP 78608 and 7-
chlorokynurenic acid (Fletcher & Lodge, 1988; Kemp et al., 1988). The 
NMDA receptor ion channel is blocked by Mg2+ ions at resting membrane 
potentials. Other modulators have also been discovered that block the ion 
channel in a non-competitive manner; notably, dizocilpine (MK 801), PCP 
and ketamine. Zinc, like other group IIB metal ions produces inhibition of 
the NMDA receptor and is selective at nanomolar concentrations to NR2A 
subunit-containing NMDA receptors (Paoletti et al., 1997). Polyamines 
such as spermine and spermidine can inhibit or potentiate the NMDA 
receptor, at high and low concentrations respectively. Polyamines promote 
channel opening at low micromolar concentrations by glycine-dependent 
and glycine-independent mechanisms (Rock & Macdonald, 1992; 
Williams, 1997). At higher concentrations, they block the channel in a 
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voltage-dependent manner. Antagonists at this site, inhibiting the NMDA 
receptor, include ifenprodil and haloperidol (Reynolds & Miller, 1989; 
Ilyin et ai., 1996; Lynch & Gallagher, 1996). Modulation also occurs at the 
Ro 25-6981 site, the redox site and with ethanol and the volatile 
anaesthetics. 
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NR1 
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Figure 1. The NMDA receptor. 
Polvamine 
Mg2+ 
NR2 
"--. { Zn2 + (MR2A) 
Ifenprodil (NR2B) 
-- Glutamate 
Extracellll/af 
A model showing the agonist binding sites for glutamate and glycine and the 
competitive antagonists that can block these sites. Additionally, other 
modulators can block the ion-channel and modulate the receptor at discrete 
sites (Kemp & McKernan, 2002). 
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AMPA and kainate receptors 
The a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMP A) and 
kainate (KA) receptors are the non-NMDA ionotropic receptor subtypes 
that activate Na+ and K+ conductances whilst the NMDA receptors activate 
Na+, K+ and Ca+ conductances (Monaghan et at., 1989; Barnard & Henley, 
1990). AMP A receptors are hetero-oligomeric proteins consisting of the 
subunits GluR1 to GluR4, each receptor comprising four subunits 
(Hollmann & Heinemann, 1994; Rosenmund et at., 1998). The AMPA and 
kainate receptors have at least three separate binding sites at which agonists 
and antagonists can act: glutamate binding, desensitisation and intra-ion 
channel binding sites. Kainate receptors consist of GluR5-7 and KA1-2 
subunits, and have approximately 40% sequence homology to AMP A 
receptor GluR1-4 subunits. High affinity binding of kainate is observed to 
the KA1 and KA2 subunits compared to low affinity binding to GluR5-7. 
The same agonists and antagonists can modulate both AMP A and kainate 
receptors with little differentiation. However, certain desensitisation 
inhibitors, which act allosterically to modulate positively sites on the ion 
channel, can distinguish between AMP A and kainate receptors (Table 3). 
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Inhibitory GABA-ergic transmission 
As well as excitatory transmission mediated by glutamate there is also the 
presence of GABA-ergic interneurones that mediate feedforward and 
feedback inhibition of excitatory transmission. Activation of these 
inhibitory interneurones by glutamate results in a dual component 
inhibitory postsynaptic potential (IPSP)(Alger & Nicoll, 1982; Benardo, 
1994). This consists of a GABAA-mediated fast component which results 
in the activation of GABAA ionotropic receptors releasing hyperpolarising 
cr ions into the neurone. The other component is a slow GABAB-
mediated component which results in the activation of the GABAB 
metabotropic receptor (Alger, 1984) leading to the hyperpolarising influx 
of K+ ions and the negative modulation of the influx of Ca2+ ions. IPSPs 
can inhibit excitatory synaptic transmission by moving the membrane 
potential to values that are more negative and increasing the amount of 
depolarisation required by EPSPs to reach the threshold for action potential 
generation. GABAB mediated slow IPSPs are possibly better poised to 
counter longer-lasting EPSPNMDA which because of their long slow kinetics 
have been reported to escape fast GABAA inhibition (Benardo, 1995) 
although one report suggested that when stimulation evokes only a small 
EPSP (2-5m V) the GABAB component is negligible (Otmakhova & 
Lisman,2004). In addition to postsynaptic GABA receptors there is also a 
presynaptic GABAB autoreceptor in the Schaffer collateral feedforward 
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interneurones (but not in the perforant pathway). When the interneurone is 
repeatedly activated, GABA is released in sufficient quantity to feedback 
on these GABAB receptors, which inhibits the release of further GABA, 
and synaptic inhibition is depressed (Davies et al., 1990). 
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Excitotoxicity 
The term excitotoxicity was first coined by John Olney who observed that a 
number of excitatory amino acids (EAAs) killed neurones in the 
hypothalamus with a potency that correlated with their efficacy in 
depolarising cells. Excitotoxicity is a critical mechanism contributing to 
neurodegeneration during ischaemia and hypoxia. Both the loss of calcium 
homeostasis and the activation of EAA receptors are postulated to be 
responsible for excitotoxic neuronal damage (Olney, 1969; 1986; Seisjo, 
1988; Choi, 1991; Sattler et al., 1999). With the activation of NMDA, 
receptors both of these hypotheses are fulfilled. The over-activation of 
NMDA receptors leads to an influx of Ca2+ resulting in necrosis or 
apoptosis by several proposed mechanisms. The subsequent activation of 
Ca2+ -sensitive enzymes (nNOS, endonucleases and proteases), the 
production of highly reactive free radical species, mitochondrial 
impairment and the activation of immediate-early response sense genes all 
contributing to neuronal death. Blockade of this influx, by NMDA 
antagonists and calcium antagonists, is neuroprotective in animal models of 
stroke and seizure (Lee et aI., 1999). The clinical use of non-selective 
NMDA receptors as neuroprotective drugs has been hindered by their 
narrow therapeutic window, which produces adverse drug reactions 
including sedation, muscular weakness, ataxia, confusion and tinnitus. 
Subunit selective antagonists such as ifenprodil have been associated with a 
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decrease in side effects allowing an effective therapeutic dose to be titrated 
(Gotti et aI., 1988). Nevertheless, therapeutic NMDA receptor antagonists 
have yet to be developed with clinical success (De Keyser et at., 1999). 
Several studies have specifically implicated both the NR2A- and NR2B-
containing NMDA receptors in excitotoxicity. Excitotoxicity in cultured 
embryonic forebrain neurones coincides with a dramatic increase in NR2B 
mRNA levels during the first 10 days, thereafter remaining stable (Cheng 
et aI., 1999). However, decreased expression of NR2A and NR2B mRNA 
has also been reported in CAl and other hippocampal areas, in response to 
a severe ischaemic insult, altering the function of the NMDA receptors 
(Zhang et aI., 1997). In addition to changes in subunit expression, 
ischaemia has also been shown to increase the tyrosine phosphorylation of 
both the NR2A and NR2B subunits thereby altering their function (Kim et 
at., 1998; Cheung et at., 2000). 
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Anatomy of the hippocampus 
The electrophysiological experiments described in this study were carried 
out in the hippocampal slice preparation of the 7-8 week old Wistar rat. 
The hippocampus along with the amygdala, adjacent regions of the limbic 
cortex and the septal area constitute the main structures of the limbic 
system. These structures form major interconnections with portions of the 
thalamus and the cerebral cortex (cingulated gyrus). 
For three reasons the hippocampus is one of the most studied areas of 
central nervous system. Firstly, it has an easily identifiable structure at the 
gross and histological levels. Secondly, it has been recognized that the 
hippocampus plays a fundamental role in learning and memory (patients 
who have had bilateral hippocampalectomy have suffered from a 
permanent loss of storing new information into their long-term memory). 
Thirdly, the hippocampus is especially susceptible to seizure disorders and 
is particularly vulnerable to the effects of ischaemia and hypoxia (Johnston 
& Amaral, 1998). 
In the brains of mammals, the hippocampus is a bilateral structure that 
appears as a ridge extending into the lateral ventricle. The outer surface of 
the hippocampus is composed of myelinated fibres, appears white and is 
called the alveus. The hippocampal formation can be divided into 
Ammon's hom, the subiculum, the dentate gyrus and the entorhinal cortex. 
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Based on the Golgi method of staining, the anatomist Lorente de N6 (1934) 
(see Johnstone & Amaral, 1998) divided Ammon's hom into four cornu 
Ammonis subfields: CAl to CA4. The designation CA4 is no longer used 
because it referred to the region occupied by the polymorphic layer of the 
dentate gyrus. CAl is equivalent to the regio superior and CA2 and CA3 
fields are equivalent to the regio inferior. A narrow transitional zone, CA2, 
separates CAl and CA3 (Figure 2). 
The dentate gyrus contains round, tightly packed neurons called granule 
cells and consists of three layers: the granule layer, which is the principal 
layer, the molecular layer above the granule cell layer and a polymorphic 
layer below the granule cell layer (Isaccson, 1987). 
In all CA fields below the alveus is the stratum oriens, which contains the 
basal dendrites of the pyramidal cells. The cell bodies are clearly visible 
under a microscope as a dark band. Below this is the stratum radiatum 
consisting of the apical dendrites of the pyramidal cells and the Schaffer 
collaterals, which are collateral branches from axons of pyramidal cells in 
the CA3 region (Cajal, 1968). 
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Neuronal circuits in the hippocampus 
The excitatory neuronal circuitry of the hippocampal formation is 
illustrated in figure 2. The functional organisation of the hippocampus has 
been described in terms of a 'trisynaptic' circuit. Information that flows 
from the neocortex into and out of the hippocampus travels in a 
unidirectional manner through this trisynaptic pathway. The entorhinal 
cortex is considered the starting point of the circuit. Neurones located in 
layer II of the entorhinal cortex give rise to the perforant pathway that 
projects through the subiculum and terminates both in the dentate gyrus and 
in the CA3 region. Neurones forming the medial entorhinal cortex produce 
axons that terminate in the middle layer of the molecular layer of the 
dentate gyrus; the outer third of the molecular layer receive axons from the 
lateral entorhinal cortex. These two components of the perforant pathway 
also terminate in the stratum lacunosum-molculare of the CA2 and CA3 
regions. N eurones located in layer III of the entorhinal cortex proj ect to the 
CA 1 and the subiculum. 
The granule cells also synapse onto neurones of the polymorphic layer, 
which supplies associational connections to other levels of the dentate 
gyrus. The CA3 pyramidal cells project heavily within the CA3 and as the 
Schaffer collateral projection to the CAl stratum radiatum and stratum 
oriens. CAl neurones project to both the subiculum and the deep layers of 
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the entorhinal cortex, which in turn produce projections back into many of 
the cortical areas that originally terminated in the entorhinal cortex. 
Therefore information sent from cortical neurones to the entorhinal cortex 
can then negotiate the complete hippocampal circuit and be returned back 
to its cortical origin (Witter, 1989). 
As well as the main excitatory circuitry, there are also inhibitory pathways 
throughout the hippocampus. Three types of interneurones control this 
circuit in the pyramidal cell layers: axo-axonic cells, basket cells and 
bistratified cells. The majority of interneurones in the hippocampus use the 
inhibitory transmitter y-aminobutyric acid (GABA). The axo-axonic cells 
synapse upon the initial segment of pyramidal neurones and have a strong 
influence over the generation of action potentials. Basket cells synapse 
onto the somata and bistratified cell synapse at apical and basal dendrites of 
the pyramidal neurones. The dendrites of these three classes of 
interneurone proj ect into the stratum radiatum and stratum oriens where 
they can encounter excitatory inputs from the Schaffer collaterals, 
commissural-association fibres and feedback synapses from local 
pyramidal neurones (lsaccson, 1987; Johnston, 1998). 
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Figure 2. Diagram showing the anatomy of the rat hippocampal formation and 
the placement of the stimulating and recording electrodes. 
A, location of the left hippocampus in rat brain. B, structure of a hippocampal 
slice showing the principal excitatory neurons. The stimulating electrode (1) 
was positioned in the stratum radiatum at the CA1/CA2 junction. Orthodromic 
population spikes and excitatory postsynaptic potentials were recorded from the 
stratum pyramidale and stratum radiatum respectively using electrodes (2) and 
(3) placed in the CA 1 region. C, hippocampal circuitry. DG, dentate gyrus; 
ENT, entorhinal cortex; mf, mossy fibre; pp, perforant pathway; rc, recurrent 
collateral; sc, Schaffer collateral; SUB, subiculum. (Revest & Longstaff, 1998). 
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The hippocampal slice preparation 
Ever since cortical slices were demonstrated to have comparable electrical 
activity with the intact animal (Yamamoto & McIlwain, 1966) the slice 
preparation has been used extensively in the study of synaptic transmission 
and electrophysiological experiments in the mammalian CNS. The studies 
leading to our present understanding of how NMDA, AMP A, and 
metabotropic glutamate receptors contribute to synaptic transmission; and 
investigations of LTD and L TP have come almost exclusively from brain 
slice studies. Hippocampal slices have also shown good conditions to 
allow intracellular recording (Yamamoto, 1972; Kerkut, 1981). The 
hippocampus is an essentially laminar structure, each transverse slice 
having the same 'trisynaptic' circuitry. The neuronal function and anatomy 
of the slice preparation, in the plane in which it is cut, is calculated to be 
similar to the intact brain producing representative electrophysiological and 
pharmacological responses. The slices should be well enough prepared to 
allow recording at physiological temperatures (36-37°C for rodent slices) 
however, this is not usually achievable and a sub-physiological temperature 
of 28-30°C is normally used. 
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Advantages of the In vitro slice preparation over III VIVO techniques 
include: 
1. Technical simplicity: it is relatively easy to record via extracellular, 
intracellular and whole-cell patch-clamp compared with in vivo 
experiments. 
2. Control over the conditions of the preparation. If one can reduce the 
number of contributory variables, greater significance can be drawn 
upon results from a constant environment (e.g. temperature, 
movement, 02/C02 saturation, absence of the influence of an 
anaesthetic maintenance dose). 
3. Improved visualization of tissue. The tissue is easily identified 
under low magnification facilitating the positioning of stimulating 
and recording electrodes. 
4. Control of the extracellular environment and the field potential to 
study neurophysiology and pharmacology. This is helpful when 
applying drugs and doses that are impractical in whole animal 
studies. 
5. Humane treatment of animals, because slice preparation does not 
require restraint or the maintenance of physiological functions it is a 
relatively more humane method. 
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6. The ability to use technically demanding methods that are difficult or 
impossible in intact preparations. For example, the ability to isolate 
specific pathways and record from specific postsynaptic cells 
without contamination of other synaptic inputs from other brain 
regions which have been dissected (Grover & Teyler, 1990), or the 
ability to use optical techniques. 
These advantages of the slice preparation have led to increasing numbers of 
neuroscientists to use this technique. However, there are also some 
disadvantages with brain slice preparations: 
1. The dissection and slicing process severs the hippocampal slices' 
normal sensory input and motor output. Long feedback loops, 
some excitatory pathways and some inhibitory pathways are also 
lost. One obvious symptom of this is the markedly lower levels of 
spontaneous activity found in the slice preparation compared to the 
intact animal. This brings into question the similarity and relevance 
of the in vitro slice preparation compared to the in VIVO 
environment. Furthermore, it has been demonstrated that 
phenomena such as LTD induction are more readily induced in 
vitro than in vivo (Bear & Abraham, 1996) 
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2. The crude method of slicing causes damage along the faces of the 
slice, this results in cell damage and the release of substances that 
may affect the slice. 
3. The tissue is subject to an anoxic period during preparation (Lipton 
& Whittingham, 1979). 
4. The ionic environment does not mImIC exactly the normal 
extracellular conditions in vivo. This is of particular relevance in 
the induction and maintenance of LTD and L TP that are dependent 
upon relative ci+ and Mg2+ ion concentrations. The continuous 
perfusion of artificial cerebrospinal fluid (ACSF) can also wash out 
any modulatory compounds endogenous to the slice (such as 
growth factors released following stimulation). 
5. The addition of drugs to the artificial cerebrospinal fluid (ACSF) 
results in the exposure of the whole slice to pharmacological 
modulation. This confounds the significance of results seen with 
the subset of cells that are being recorded. 
6. Finally, the diversity of methods used in each brain slice laboratory 
makes the comparison of findings difficult (Lipton et aI., 1995). 
The most obvious differences include: (A) the maintenance of brain 
slices at the interface of the ACSF and oxygenated atmosphere 
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versus those maintained entirely submerged in ACSF, (B) cutting 
brain slices on a manual tissue chopper versus a vibratome or a 
vibraslice, (C) differing ACSF recipes and (D) temperature 
differences. 
Extracellular responses 
Single electrical stimulations of the Schaffer collaterals result in a 
distinctive sequence of excitation followed by inhibition in the target CAl 
pyramidal neurones. Field extracellular recordings represent the summed 
responses from a population of neurones close to the recording electrode. 
The field excitatory postsynaptic potential (fEPSP) recorded in the stratum 
radiatum consists of an initial fibre volley of action potentials in the 
presynaptic fibres producing a negative-going transient; this is followed by 
a slower negative-going potential with a time-period similar to that of the 
underlying synaptic currents. The current flowing into these dendrites 
during the fEPSP will exit the neurons near the cell body layer in the 
stratum pyramidale where a recording electrode will record a concurrent 
positive going potential. If the strength of the synaptic input is adequate to 
evoke action potentials in the neurons, then a negative-going potential 
(population spike) can also be recorded in the stratum pyramidale resulting 
from the inward current during the postsynaptic action potentials. 
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Paired-pulse interactions 
The magnitude of synaptic transmission in the mammalian brain can be 
modulated in different ways. Two examples of such modulation are 
paired-pulse facilitation (PPF) and paired-pulse depression (PPD). 
Paired-pulse facilitation 
Paired-pulse facilitation (PPF) is a form of short-term plasticity in which 
the synaptic response to the test pulse (second stimulus) given after the 
conditioning pulse (first stimulus) is enhanced in comparison to the 
conditioning pulse when interstimulus intervals are relatively long 
(~20ms). The most widely accepted hypothesis to explain the mechanism 
of PPF is based on the accumulation of presynaptic ci+ after the first 
stimulation. The first pulse induces a Ca2+ influx that lingers in the 
presynaptic terminal for several hundred milliseconds. This residual Ca2+ 
combined with fresh Ca2+ entering during the second pulse leads to the 
increased transmitter release (Katz & Miledi, 1968; Thomson, 2000; 
Zucker & Regehr, 2002). The Ca2+ concentration in the presynaptic nerve 
terminal affects directly the release probability of neurotransmitter. 
Furthermore, reports at the neuromuscular junction have suggested that the 
second of the two action potentials induces release with higher probability 
than the first one because of a small but persistent increase of the 
intracellular Ca2+ concentration in the axon terminal. This residual Ca2+ 
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can enhance the release probability by increasing the fusion of synaptic 
vesicles with the presynaptic membrane and enhancing the number of 
vesicles released by the action potential (Katz & Miledi, 1968; Mennerick 
& Zorumski, 1995; Debanne et at., 1996). Neuromodulators and 
physiological processes that alter transmitter release probability also affect 
the paired-pulse ratio. Increasing the external Mg2+/Ca2+ ratio (Davies & 
Collingridge, 1993; Lambert & Wilson, 1994; Wilcox & Dichter, 1994) 
and applying adenosine (Lupica et at., 1992; Higgins & Stone, 1995) 
decreases the probability of release of neurotransmitter during the first 
stimulus and increases the probability of release by the second stimulus 
producing enhanced PPF. In the hippocampus, PPF of excitatory synaptic 
potentials in the CAl and CA3 is observed when large numbers of axon are 
concurrently stimulated (Creager et at., 1980; Manabe et at., 1993) 
whereas, during conditions in which the release probability is enhanced by 
decreasing the Mg2+/Ca2+ ratio then PPF is reduced (Nathan et at., 1990; 
Kahle & Cotman, 1993). 
Paired-pulse depression 
When two evoked potentials are elicited when interstimulus intervals are 
small «1 Oms), the size of the second response is smaller than the first, a 
phenomenon called paired-pulse depression (PPD). The mechanism 
underlying PPD of synaptic transmission is unclear. One hypothesis is the 
activation of GABAB autoreceptors (Deisz & Prince, 1989), but studies 
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have shown that GABAB receptor antagonists did not attenuate PPD of 
unitary inhibitory post synaptic potentials (IPSPs) in pairs of cultured 
hippocampal neurons (Wilcox & Dichter, 1994). An alternative presynaptic 
mechanism for PPD is a transient decrease in the quantal content caused by 
depletion of the readily releasable vesicle pool by the first stimulus 
(Mennerick & Zorumski, 1995; Stevens & Wang, 1995; Debanne et al., 
1996). Postsynaptic mechanisms such as the desensitisation of GABAA 
receptors (Alger, 1991) and a reduced driving force due to intracellular 
accumulation of chlorine ions and/or extracellular accumulation of 
potassium ions may also explain PPD (McCarren & Alger, 1985). Since 
paired-pulse depression is observed most clearly and reliably when the 
interstimulus interval is around 15-100 ms, which corresponds to the time 
course of the GABAA mediated fast inhibitory potential recorded 
intracellularly in pyramidal cells (Davies et al., 1990), it is thought to be 
largely caused by the activation of GABAA receptors (Wilcox & Dichter, 
1994). It is difficult to test this proposition using bath application of 
GABAA receptor antagonists such as bicuculline which increase the 
excitability of the pyramidal cells by blocking the effects of spontaneously 
released GABA. 
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Whilst changes in paired-pulse interactions are widely considered to be due 
to presynaptic alterations in release probability; when studied on fEPSPs 
and especially where there are depolarisation-induced changes in the size 
of the postsynaptic potential in response to the test agents many factors 
affect them which can confound the interpretation. These include changes 
in presynaptic release probability (Andreasen & Hablitz, 1994), activity of 
presynaptic autoreceptors on inhibitory or excitatory terminals (Davies et 
at., 1990; Stanford et at., 1995), modulation of postsynaptic conductances 
(e.g. voltage-dependent NMDA receptor) and the presence of GABA-ergic 
inhibition following the fEPSP and the depression cause by NMDA agonist 
action (Duguid & Smart, 2004). In particular, it has been reported that 
there is a non-linear inverse relationship between feedforward inhibition 
and the NMDA dependent PPF component of the fEPSP 
(Papatheodoropoulos & Kostopoulos, 1998) although, this NMDA-
component of PPF is manifested by an increase in the duration of the 
fEPSP and not the amplitude of the slope. 
In hippocampal slices paired-pulse inhibition has been reported at 
interstimulus intervals less than 40 ms and in the present experiments at 
less than 20 ms while PPF is observed at longer time intervals (20 and 50 
IDS) (Lynch et at., 1983; Higgins & Stone, 1995; Nikbakht & Stone, 2000). 
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Aims 
1. To investigate NMDA receptor subunit pharmacology in the intact, 
adult hippocampal slice preparation using the newly developed 
NR2A and NR2B subunit-selective NMDA receptor antagonists 
Ro 25-6981 and PEAQX. 
2. To address the contribution of NR2A and NR2B subunit-containing 
NMDA receptors in the induction of NMDA receptor dependent 
synaptic plasticity in the Schaffer collateral-CAl pyramidal synapse. 
3. A report had suggested that the NR2AJ2B subunit selective NMDA 
receptor agonist homoquinolinic acid was binding to a novel 
NMDA-insensitive site in the brain. An investigation of NMDA 
insensitive effects on the fEPSP was undertaken to reveal any 
residual effects. 
Furthermore, the selectivity of homoquinolinic acid allowed the 
investigation of the NR2A and NR2B components of the previous 
study (1) and to find evidence for the involvement of the NR2D 
subunit. In addition, this study investigated changes of paired-pulse 
interactions using these compounds. 
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Chapter 2. Material and methods 
Preparation of hippocampal slices 
Male Wistar rats (130-180g, 7-8 weeks) were anaesthetised by an 
intraperitoneal injection of urethane solution (1.5 g/Kg); urethane has been 
shown not to interfere with synaptic plasticity, a problem encountered 
when using phenobarbitone (unpublished observations). The animals were 
then killed by cervical dislocation, decapitated using a guillotine, and the 
brain gently and rapidly removed to ice-cold and oxygenated artificial 
cerebrospinal fluid (ACSF). The intact brain was kept cold and moist by 
copious amounts of ACSF whilst it was transferred to a petri dish lined 
with filter paper to prevent sliding. The cerebellum was removed and the 
two cerebral hemispheres were separated with a scalpel blade. Each 
hippocampus was dissected free from the surrounding tissue using small 
spatulas and cut transversely using a McIlwain tissue chopper into slices 
450~m thick, perpendicular to their longitudinal axis. The slices were 
gently separated from each other using blunt glass microelectrodes to 
ensure that they receive adequate amounts of oxygen and nutrients and to 
allow individual slices to be transferred easily. The slices were incubated 
at room temperature (21-230C) on a fresh filter paper lined petri dish 
containing a small amount of freshly gassed ACSF to cover the slices. The 
petri dish was kept in an incubation chamber saturated in an atmosphere of 
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95% O2 and 5% CO2 for at least 1 hour prior to individual slices being 
transferred to the recording chamber. 
Composition of ACSF 
The composition of the ACSF was (in mM): KH2P04 2.2, KC12, NaHC03 
25, NaCll15, CaCh 2.5, MgS04 1.2, and glucose 10. It was gassed with a 
mixture of95% O2 and 5% CO2 yielding a pH ,..,7.4. 
Bath superfusion and application of drugs 
Following incubation, individual slices were transferred to a I ml 
submerged recording chamber using a wide tipped plastic Pasteur pipette. 
A seeker wire, the end of which was modified in such a way as to form a ~ 
shape was used to gently hold the slice in place. The slice was left to 
stabilise whilst being continuously superfused with ACSF by a gravity-fed 
silicone tube at a rate of 4 ml/min. The ACSF was kept saturated with 95% 
O2 and 5% CO2 and heated using a thermostatically controlled water bath 
to 28-30°C. Drugs were added to the ACSF and fed via a three-way tap 
through the silicon tubing to the recording chamber. Due to the length of 
tubing, it took 1 minute for fluid to reach the recording chamber. To 
prevent the build-up of organic matter the silicon tubing and recording 
chamber were flushed with distilled water before and after use. 
Additionally, the system was more aggressively cleaned using diluted 
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bleach once a month and the tubing replaced every six months and as 
required. 
Stimulation 
Stimuli were AC amplified square wave constant-current pluses of 300~s 
duration. Paired stimuli, where used, were delivered through the same 
electrode. The slices were stimulated using a concentric bipolar electrode 
(Clark Electromedical Instruments Ltd, Harvard Apparatus) positioned in 
the stratum radiatum near the commissural border of CAlICA2 for 
orthodromic activation of pyramidal cells. The slice was briefly and 
occasionally stimulated at I Hertz (Hz) until a population of neurones was 
identified; once this was achieved, a stimulus frequency of 0.05Hz was 
used. The population of neurones was then allowed to stabilise. 
Population spikes were recorded at 70% of maximum amplitude whilst 
ffiPSP slopes were recorded at 50% of their maximum amplitudes. Only 
field responses that produced clear ffiPSP and population spikes with 
maximum amplitudes greater than 2m V were used in experiments. 
Furthermore, responses that showed greater than 5% drift over the 20-
minute baseline-recording period were excluded (Figure 3). 
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Figure 3. Example responses recorded from the CA 1 region of the rat 
hippocampal slice. 
Trace (A) shows a population spike recorded from the stratum pyramidale and 
trace (8) shows a fEPSP, recorded from the stratum radiatum. 
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Recording 
Extracellular population spike potentials and field excitatory postsynaptic 
potentials (fEPSPs) were recorded extracellularly from the stratum 
pyramidale and the stratum radiatum, respectively, using borosilicate glass 
microelectrodes, which were produced on a Kopf vertical puller. The 
electrode tips were broken back to produce an opening 2-4~m in diameter 
under low magnification using a glass probe, resistances approximately 2-
5MQ. The electrodes were filled with sodium chloride 0.9% solution using 
a fine 36-gauge needle. 
Evoked responses were amplified through a Neurolog system, displayed on 
a digital oscilloscope and recorded onto a personal computer via a 
Cambridge Electronic Device (CED) micro 1401 interface and Signal 
analysis software (Cambridge Electronic Design, version 1). Responses 
were filtered between DC and 5kHz; line frequency interference was 
removed by digitally filtering (Humbug, Digitimer Ltd). 
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Data analysis 
Responses were quantified as the amplitude of the population spike in m V 
(measured as the difference between peak negativity and the averaged 
values of the two peaks of the positive-going synaptic potential) and the 
fEPSP was measured as the maximum slope of the initial negative going 
gradient with two static cursors using Signal software; manually selecting 
and recording the slope in response to changes in the size of the fEPSP 
response and electrical interference (figure 3). Individual responses were 
measured, normalised and compared to the 20-minute initial baseline 
recordings. Every time point was pooled and graphed using GraphPad 
Prism software (GraphPad Prism Software, San Diego, CA, version 3) 
showing mean ± standard error of the mean (s.e.m.). Rarely, single 
responses had to be excluded due to anomalous electrical interference 
disrupting the recording of evoked responses. 
When paired-pulse interactions were investigated, inhibition or facilitation 
was expressed as the ratio of the second response of a pair compared with 
the first response. 
Statistical analysis 
The statistical significance of a difference was assessed on raw data by a 
paired Student's t-test or, if the difference was between three or more 
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means, significance was calculated with a one-way or repeated measures 
analysis of variance (ANOV A) followed by a Student-Newman-Keuls 
post-test using GraphPad Prism software; p values less than 0.05 were 
considered statistically significant. IC50 and EC50 values were calculated 
using GraphPad Prism software by generating non-linear regression, 
sigmoidal concentration-response curves. In the figures statistically 
differences between data points are sometimes indicated by asterisks: 
* p<0.05; ** p<0.01; *** p<O.OOl. 
Chemical agents and drugs 
Constituents of ACSF were of analar grade and were dissolved in distilled 
water to prepare fresh every day. N-Methyl-D-aspartic acid (NMDA) , 
D-(-)-2-amino-5-phosphonopentanoic acid (2-AP5), dizocilpine (MK 801), 
zinc acetate (Zn2+), (RS)-AMPA hydrobromide (AMP A) and kainate (KA) 
were dissolved in distilled water to obtain stock solutions. Quinolinic acid 
(QA) and homoquinolinic acid (HQA) were dissolved in 1 molar 
equivalencies of NaOH to give stock solutions. Dimethyl sulphoxide 
(DMSO) was used to dissolve kynurenic acid (KYA) , 2-carboxy-3-
carboxymethylquinoline (CCMQ), okadaic acid (OA), anisomycin, (R:(*), 
S:(*))-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethy1)-1-
piperidinepropanol (Ro 25-6981), staurosporine (STA) and 1,3-dipropyl-8-
cyclopentyl-xanthine (DPCPX) to produce stock solutions. The final 
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concentration of DMSO never exceeded 0.1 % when applying these agents 
to slices; furthermore, control applications of DMSO 0.1% alone had no 
effect compared to baseline field recordings. Cyclosporin A (CyA) and 
(R)-[(S)-I-( 4-bromo-phenyl)-ethylamino ]-(2,3-dioxo-l ,2,3,4-
tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (PEAQX) were 
dissolved in ethanol. 
The majority of drugs were obtained from Tocris Cookson Ltd, analar 
grade compounds were obtained from BDH chemicals Ltd. UK. NMDA 
was obtained from Sigma chemical Co. Ltd. Ro 25-6981 was a gift from 
Dr Georg J aeschke of F. Hoffmann-LaRoche AG Roche pharmaceuticals 
and PEAQX was a gift from Dr Yves Auberson of Novartis 
Pharmaceuticals (table 4). 
Compound Supplier Stock solution 
NMDA Sigma chemical Co. Ltd H2O 
2-AP5 Tocris Cookson Ltd H2O 
MK801 Tocris Cookson Ltd H2O 
AMPA Tocris Cookson Ltd H2O 
kainate Tocris Cookson Ltd H2O 
quinolinic acid Tocris Cookson Ltd NaOH 1M equivalencies 
homoquinolinic acid Tocris Cookson Ltd NaOH 1M equivalencies 
CCMQ Tocris Cookson Ltd DMSOO.1% 
kynurenic acid Tocris Cookson Ltd DMSOO.1% 
okadaic acid Tocris Cookson Ltd DMSOO.1% 
. . Tocris Cookson Ltd DMSOO.1% amsomycm 
Ro 25-6981 F. Hoffinann-LaRoche DMSO O.l% 
staurosporine Tocris Cookson Ltd DMSOO.1% 
DPCPX Tocris Cookson Ltd DMSOO.1% 
cyclosporin A Tocris Cookson Ltd Ethanol 
PEAQX Novartis Pharmaceuticals Ethanol 
Table 4. List of pharmacological agents, suppliers and solvents used to 
produce stock solution. 
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Chapter 3. The negative coupling of NR2B to 
NR2A subunit-containing receptors. 
Introduction 
There has been a considerable amount of research over the last 10 years 
that has identified the NR2B subunit as being especially important in 
determining the function of the NMDA receptor. For example, in forming 
the glutamate binding site (Laube et aI., 1997), controlling the Mg2+ block 
(Williams et al., 1998) and in a variety of phenomena including learning 
and memory formation, synaptic plasticity (Hrabetova et aI., 2000), pain 
(Chizh et aI., 2001), schizophrenia (Grimwood et aI., 1999; Gao et al., 
2000), Parkinson's disease (Nash et al., 1999; Oh et al., 1999; Dunah et al., 
2000; Steece Collier et al., 2000), Huntington's disease (Chen et al., 1999; 
Zeron et al., 2001) and excitotoxicity (Zhang et al., 1997; Cheng et al., 
1999). The NR2B subunit consists of 1456 amino acids with a molecular 
weight of approximately 170-180 kDa. All of the NR2 subunits have the 
same basic structure as the NR1 subunit (Hollmann & Heinemann, 1994) 
but varying in that they have an especially large intracellular C-terminal 
domain. This C-terminal domain, it has been suggested, plays a role as the 
target for modulatory or accessory proteins in promoting receptor 
assembly, sorting or targeting and playing a part in different channel 
conformations to modulate receptor function (Kohr et aI., 2003; Loftis & 
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Janowsky, 2003). The NR2B subunit is modulated by its co-assembly with 
other subunits, alterations in the interaction with associated proteins such as 
PSD-95 and SAP102, proteases, growth factors, hormones and post-
translational modifications such as phosphorylation. The phosphorylation 
of tyrosine residues can contribute to enhanced receptor responses and 
signal transduction into the neurone (Gurd, 1985; Gurd & Bissoon, 1997; 
Hisatsune et al., 1999; Manabe et al., 2000; Nakazawa et al., 2001). 
Receptor function is also modulated by the phosphorylation of serine 
residues by protein kinase A (PKA) , protein kinase C (PKC), and 
calmodulin-dependent protein kinase II (CaMKII) (Smart, 1997). 
Ro 25-6981 is an ifenprodil derivative that has high affinity and selectivity 
for the NR2B subunit-containing NMDA receptor but without the affinity 
for aI-adrenergic and serotonergic receptors found with ifenprodil itself 
(Chenard et al., 1991; McCool & Lovinger, 1995). It is a high affinity, 
selective (5000-fold greater for the NR2B than the NR2A subunit), 
activity-dependent, voltage-independent and non-competitive NR2B 
subunit-containing NMDA receptor antagonist (Fischer et al., 1997; Mutel 
et al., 1998; Lynch et al., 2001). 
F. Hoffman-La Roche Pharmaceuticals first described Ro 25-6981 in 1997. 
They used cloned NMDA receptors expressing NR1cINR2A, NRlclNR2B 
and NR1flNR2B subunits to confirm that Ro 25-6981 was selective for the 
NR2B subunit-containing receptors. 
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They also studied the 
electrophysiology of Ro 25-6981 in young cultured rat cortical neurones, 
which express NR2B as the dominant NMDA receptor subunit. It was 
observed that the effect of Ro 25-6981 was dependent upon the relative 
level of NMDA receptor activation. Ro 25-6981 potently blocked the 
current evoked by NMDA lOOIlM but it potentiated the slight responses to 
NMDA 11lM. Protons (H+) exert a tonic inhibition of the NMDA receptor 
with an ICso at physiological pH 7.4 by binding at a proton sensor site. The 
NR2A and NR2B subunit-containing NMDA receptors are the most 
sensitive to this effect. The proton sensor's binding site overlaps 
structurally and mechanistically with the binding site of Ro 25-6981, 
ifenprodil and the endogenous modulators spermine and spermidine (Mott 
et al., 1998). The binding stabilises a protonated, agonist-bound state of 
the receptor that has a low open probability. This shifts the pKa of the 
proton sensor to values that are more alkaline and increases tonic 
inhibition. However, the potentiation of responses to NMDA by these 
compounds is reported to be due to an allosteric modulation with the 
glutamate and glycine binding sites. The binding of these compounds 
causes a decrease in NMDA receptor affinity for glycine and an increase in 
affinity for glutamate and NMDA leading to potentiation. However, while 
ifenprodil and Ro 25-6981 both bind to the N-terminal third of the NR2B 
receptor, Ro 25-6981 has a distinct binding site that has greater three-
dimensional requirements. Furthermore, the binding of ifenprodil is 
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decreased and its IC50 is increased by rising concentrations of spermidine 
whilst under the same conditions the binding of Ro 25-6981 is unaffected 
and its IC50 decreases (Kew et al., 1996; Kew et al., 1998b; Grimwood et 
al., 2000; Lynch et al., 2001; Perin-Dureau et al., 2002). In addition, Ro 
25-6981 had no direct effect on the ion channel as seen with ifenprodii. 
This clearly demonstrates distinct properties of action by Ro 25-6981, 
which have not yet been fully investigated. This activity-dependent 
property is of great significance in therapeutic development as it predicts 
that NMDA receptors that are pathologically and continuously activated 
will be blocked whilst leaving inactive receptors relatively unaffected. In 
neuroprotective experiments, Ro 25-6981 was found to be very effective in 
protecting cultured cortical neurones from excitotoxic and ischaemic 
insults (Fischer et al., 1997). 
A further study followed, using autoradiography to investigate the binding 
of Ro 25-6981 to adult rat brain membranes and tissue sections. It was 
observed that Ro 25-6981 binding was similar to NR2B subunit 
distribution and dissimilar to NR2A subunit distribution (Mutel et aI., 
1998). 
More recently, a study of Ro 25-6981 was carried out to characterise its 
NR2B selective pharmacology using human embryonic kidney (HEK) 293 
cells transfected with heterodimers consisting of NRI a and either wildtype, 
chimeric or mutant NR2B subunits (Lynch et al., 2001) which co-assemble 
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into tetrameric or pentameric receptors. It was observed that specific 
regions of the N-terminal leucine/isoleucine/valine-binding protein 
(LIVBP)-like domain of the NR2B subunit protein modulated the 
interaction between Ro 25-6981 and the NMDA receptor. Ro 25-6981 may 
be binding directly to the NR2B subunit or indirectly to the NR1 subunit at 
a site that is modulated by the NR2B subunit in a way that is analogous to 
glycine binding to the NRl subunit where the NR2 subunit influences 
glycine affinity (Gallagher et al., 1996; Masuko et al., 1999; Perin-Dureau 
et a!., 2002). Whilst Ro 25-6981 is an ifenprodil analogue it has a binding 
site and pharmacology that is distinct from the polyamine site (Lynch et al., 
2001). 
Although there are several NR2B antagonists available, Ro 25-6981 is the 
first compound to be developed that is a highly selective and full antagonist 
at NR2B subunit-containing NMDA receptors. Ifenprodil is a partial 
antagonist only inhibiting NR11NR2B receptors by 80% on average and 
affecting NR11NR2A!NR2B receptors with little (Luo et al., 1997) or 
intermediate effect (Tovar & Westbrook, 1999). Also, ifenprodi1 is not 
very selective for the NR2B subunit (400-fold, recombinant NR11NR2B 
compared to NR1INR2A) and also blocks aI-adrenergic, 5HT lA, 5HT 2, 
5HT3 and sigma receptors and N, P and Q type calcium channels (Chenard 
et al., 1991; McCool & Lovinger, 1995). Interestingly, Pfizer has recently 
developed an NR2B subunit-selective antagonist CP-10 1, 606, which has a 
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very low affinity for the NR11NR2A1NR2B synaptic receptors but a high 
affinity for the purely extrasynaptic NR11NR2B population (Chenard et al., 
1995; Tovar & Westbrook, 1999). It would be of particular interest to 
repeat this study using CP-101, 606 to investigate further the contribution 
of synaptic versus extrasynaptic receptor populations (Hardingham et al., 
2002). There have been several recent reports demonstrating that the 
different subunit-containing NMDA receptors and the locus of activation 
has a great effect on determining the direction of synaptic plasticity (Liu et 
al., 2004; Massey et al., 2004; Rusakov et al., 2004; Wong et al., 2004; 
Mallon et al., 2005) and the phosphorylation of CREB (cAMP response 
element binding protein) leading to BDNF expression and pro-survival 
pathways (Hardingham et al., 2002; Riccio & Ginty, 2002). 
Novartis Pharmaceuticals have recently developed an NR2A subunit-
containing NMDA receptor antagonist (R)-[(S)-l-( 4-bromo-phenyl)-
ethyl amino ]-(2,3-dioxo-1 ,2,3 ,4-tetrahydroquinoxalin-5-yl)-methyl]-
phosphonic acid (PEAQX, also known as NVP-AAM077, appendix 2). 
PEAQX is a water-soluble 5-methyl-quinoxalinedione with a high affinity 
for the glutamate-binding site of the NMDA receptor ([3H]-CGP39653 
binding assay: ICso = llnM). At lOflM PEAQX showed no additional 
activity in a series of 68 radio ligand binding assays for CNS receptors. 
PEAQX has 126-fold selectivity for the NMDA NR1A1NR2A over the 
NR1A1NR2B receptors expressed in Xenopus oocytes (IC50 = 14nM and 
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1800nM respectively). Experiments on embryonic cortical cells and on 
neocortical slices have confirmed these results with native receptors. 
Cultured embryonic cortical cells express NR2A subunits at a very low 
level, resulting in a low potency of PEAQX (ICso = 1 ~M). In adult slices 
where NR2A subunits are predominantly expressed the effect of PEAQX is 
stronger (IC50 = 68nM) than in cultured embryonic cortical cells that 
express NR2A at very low levels (undetectable) (ICso = 1 ~M). 
Furthermore, in vivo PEAQX was found to be a potent anticonvulsant 
following intravenous dosing with few of the side effects associated with 
non-selective or NR2B selective antagonists (Auberson et al., 2002). 
Although these compounds have been examined on recombinant receptors 
and immature cultures, which are systems that over-express the NR2B 
subunit-containing NMDA receptors, this study has used these compounds 
to examine the role of NR2 subunits in an intact neuronal network in which 
adult heteromeric NMDA receptors are involved in synaptic transmission 
and plasticity. Of great importance in this study was the use of adult 
animals that are 7-8 weeks old because they are past the 3rd postnatal-week 
threshold for the maturation ofNMDA receptor subunit expression (where 
NR2A subunits are the last to reach their mature levels) and the 4th 
postnatal-week threshold during which the basal levels of receptor tyrosine 
phosphorylation are attained (Cudmore & Gurd, 1991; Tovar & Westbrook, 
1999). 
71 
Results 
NMDA 
We started this study usmg lO-minute applications of NMDA, which 
reversibly depressed the slope of the fEPSP. The depression of fEPSP 
slope being a reflection of changes in membrane conductance and 
depolarisation of the neurones. This leads to the depolarisation block of the 
CAl neurones recorded from and the subsequent blockade of excitatory 
transmission. The concentration-response relationship was very steep, with 
l/-lM having had no effect, 4/-lM producing a response that was discernible 
but not statistically significant, while 7.5/-lM produced a depression to 
69.36±16.33%, lO/-lM produced a depression to l5.l8±4.43% (Figure 5) 
and 20/-lM producing a depression to -1.05±1.61 % of fEPSP slope (Figure 
4). Furthermore, investigation of changes to the paired-pulse paradigm 
during the depression elicited by NMDA lO/-lM found a significant 
decrease of paired-pulse inhibition, and increase of paired-pulse facilitation 
at all interstimulus intervals (lOms p<O.OOl, 20ms, p<O.Ol and 50ms 
p<O.Ol, n=5) (Figure 6 and 7). 
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Figure 4. Concentration curve of the inhibitory effect of NMDA upon fEPSP 
slope. 
Graph showing the non-cumulative concentration-response curve of depression 
of fEPSP slope in response to 10-minute applications of NMDA concentrations 
of 1~M, 4~M, 7.5~M, 10~M and 20~M, n=4, 13, 4, 8 and 4 respectively. A 
concentration of 8.6~M is predicted to cause a 50% depression of fEPSP slope. 
Each point shows the mean±s.e.m. 
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II NMDA 10flM 
Figure 5. Effect of NMDA 10flM on fEPSP slope. 
Plot showing the effect of a 10-minute application of 10IJM NMDA, which elicits 
a depression in the slope to 15.18±4.43% of fEPSP (p<O.001). Points (c), (1) 
and (2) indicate the timing of the paired-pulse tests summarised in Figure 6. 
Each point shows the mean±s.e.m. for n=8 experiments. 
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Figure 6. Effect of NMDA 10!-lM on paired-pulse interactions. 
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Graph showing the paired-pulse interactions of fEPSP slope at interstimulus 
intervals of 10ms, 20ms and 50ms during the baseline control responses (c), 
10!-lM NMDA (1) and the washout period (2) (10ms p<O.001, 20ms p<O.01, 
50ms p<O.01, n=5, 1 compared to 2 and c)(see plot in figure 5 for 
corresponding times points and example records in figure 7). Each point shows 
the mean±s.e.m. for n=5 experiments. 
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Figure 7. Example records of paired-pulse interactions during baseline 
recording and under the influence of 10IJM NMDA. 
Showing paired-pulse interactions recorded during baseline recording: (a) 10ms 
(b) 20ms and (c) 50ms and during the depression caused by NMDA 10~M: (d) 
10ms (e) 20ms and (f) 50ms (points relate to same pOints in figures 5 and 6). 
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Ro 25-6981 
The large depressions of fEPSP slope elicited by applications of NMDA 
were caused by the activation of native heteromeric NMDA receptors 
containing a combination ofNR1, NR2A, NR2B and NR2D subunits. This 
study investigated the contribution of NR2B subunit-containing NMDA 
receptors using the NR2B antagonist Ro 25-6981. A concentration of 3 ~ 
Ro 25-6981 was chosen as it has previously been shown to block 
selectively the NR2B component of the NMDA excitatory postsynaptic 
current (NMDAEPSc) in 3-4 week old rats and not the NR2A component 
(Liu et al., 2004). Repeated applications of NMDA 10J.lM caused two 
similar reversible depressions of fEPSP slope to 16.06±9.16% then to 
12.85±7.85% (p<0.001, n=4). The co-application of3J.lM Ro 25-6981 had 
no immediate effect upon this depression, which again reversibly depressed 
the fEPSP slope to 8.96±2.77% (p<0.001, n=4). However, the next 10-
minute application of NMDA started 5 minutes after the end of the 20-
minute application of Ro 25-6981 3 J.lM totally abolished the fEPSP, which 
then slowly and partially recovered to 37.56±7.26% of the baseline 
responses and remained depressed for at least the 100 minutes recorded 
(p<0.001, n=4) (figure 8 and 9). Attempts to recover the response by 
increasing afferent stimulation or by HFS stimulation, which normally 
induces LTP (responses not shown), were unsuccessful. This observation 
is consistent with a terminal excitotoxic insult to the neurones recorded 
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from and inconsistent with the induction of LTD as witnessed by the failure 
to reverse it with an L TP inducing protocol or by increasing the stimulation 
of the presynaptic afferents (Schurr et aI., 1995). 
Following the intensity of the response to lOI-LM NMDA, a concentration of 
NMDA 4I-LM was used, a concentration that produced a smaller control 
depression of baseline fEPSP slope (figure 10). This would be less likely 
to result in an excitotoxic insult after the application of Ro 25-6981. 
Applications of NMDA 4I-LM caused two small yet discernible depressions 
of fEPSP slope that were not statistically significant (i and ii). Again the 
co-application of Ro 25-6981 3I-LM with a third application of NMDA (iii) 
had no immediate effect but a fourth application, during the washout phase 
of Ro 25-6981 (iv), showed a significant enhancement of the depression of 
fEPSP slope. The fifth application of NMDA (v) caused an even greater 
depression of fEPSP slope that was matched in size by the sixth and 
seventh (vi and vii) applications with no washout of the effect being 
observed up to 100 minutes after Ro 25-6981 had been removed from the 
perfusate (significant depressions of fEPSP slope to (iv) 40.94±4.56%, (v) 
19.78±6.7%, (vi) 19.28±10.74% and (vii) 13.23±4.18% (all p<O.OOl 
compared to the second NMDA 4I-LM induced depression, n=4)). Lastly, 
the application of the NR2A subunit-selective antagonist PEAQX O.lI-LM 
during the eighth and final application of NMDA 4I-LM (viii) completely 
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blocked any depression of fEPSP slope i.e. both the initial control NMDA 
4~M portion and the enhanced portion induced by Ro 25-6981 (figure 10). 
This study also investigated the effect of Ro 25-6981 upon responses to 
low concentrations of NMDA using intracellular recording techniques to 
investigate the effect solely on the excitability of the postsynaptic 
pyramidal cell (Appendix 1). A similar enhancement of responses to 
NMDA was induced over the same time course as seen with extracellular 
recordings. This suggests a predominantly postsynaptic site of action for 
these effects. 
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Figure 8. Repeated 10-minute applications of 10j..lM NMDA and the effect of 
3j..1M Ro 25-6981. 
Plot showing the co-application of 3j..1M Ro 25-6981 had no immediate effect 
upon the response to 10j..lM NMDA, whereas the next application of NMDA was 
potentiated to the extent that the fEPSP was initially abolished and then shows 
only partial recovery (p<O.001, n=4). Each point shows the mean±s.e.m. for 
n=4 experiments. 
80 
1 
2 
lmV 
5 ms 
Figure 9. Representative fEPSPs showing excitotoxic damage. 
Recordings of fEPSPs showing the irrecoverable depression of baseline 
responses caused by the excitotoxic insult of NMDA 10l-lM and Ro 25-6981 
31-lM (2) compared with baseline responses (1). Numbered traces correspond 
to the time course in figure 8. 
81 
II NMDA4~M 
Ro 25-6981 3~M 
PEAQX O.1~M 
(1) 12 c. 
. .. . . .. 
1 11 111 IV V VI Vll Vll1 
0 
-tn 10 
c.. 
en 
c.. 8 w 
.... 
(1) 6 c: 
.-
-(1) 
4 tn ca 
.c 
.... 2 0 
~ 0 
, , , , , i 
o 50 100 150 200 250 
time (mins) 
Figure 10. Effect of Ro 25-6981 and NMDA 4~M on fEPSP slope. 
Plot showing the effect of repeated 10-minute applications of 4j..1M NMDA, which 
produced a small depression of the fEPSP slope. The application of 3j..1M Ro 
25-6981 had no immediate effect upon this, but subsequent applications of 4j..1M 
NMDA show the development of potentiation in the fEPSP slope (p<O.001, 
n=4). The co-application of PEAQX at O.1j..1M completely blocked the final 
potentiated response to NMDA. Each point shows the mean±s.e.m. for n=4 
experiments 
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NMDA receptor antagonism 
A surprising feature of these experiments was that the effect of Ro 25-6981 
developed slowly, required at least 20 minutes to elicit a clearly significant 
decrease in response size and the effect gradually continued to develop 
during the washout phase. In addition this effect, once fully developed, 
was long lasting, with no attenuation of the depressed response size being 
observed for up to 100 minutes post-washout. The continuous bath-
application of NMDA 4f.!M was employed in order to observe better how 
the effect of Ro 25-6981 developed. As shown in figure 11, NMDA 4f.!M 
initially produced a small, stable depression of baseline fEPSP slope, the 
co-perfusion of Ro 25-6981 3f.!M produced a slight recovery of the 
responses but near the end of the 20-minute perfusion the depression 
gradually develops. As Ro 25-6981 started to washout the depression had 
reached 70.42±12.18% of baseline fEPSP slope. In spite of the absence of 
perfusing Ro 25-6981 the depression continued to gradually develop. The 
depression stabilised 30 minutes after the washout of Ro 25-6981 at 
33.84±0.32% (p<0.001; n=5) of baseline fEPSP slope. The application of 
the competitive, non-selective NMDA receptor antagonist 2-AP5 50llM 
reversed the depression to near-baseline responses. However, after the 
washout of 2-AP5 the depression reasserted itself within approximately 18 
minutes (p<O.OOl; n=5). At the end of the experiment and with the 
washout of NMDA, the fEPSP slope returned to a level not significantly 
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different from the initial baseline responses (Figure 11). An examination 
of paired-pulse interactions during this experiment found that paired-pulse 
ratios were enhanced during the Ro 2S-6981-mediated enhancement of 
NMDA 4f.lM (p<O.OOI, n=S at all interstimulus intervals) but were returned 
to baseline responses during the reversal of this depression caused by 2-
APS (figure 12). 
Repeating the same protocol using a slightly higher level of NMDA at a 
concentration of 7 .S f.lM (figure 13) produced a modest and stable 
depression of fEPSP slope to 64.6±10.4% (not significant, n=4). The co-
application of Ro 2S-698l 3 f.lM caused an enhancement of this depression, 
which started during Ro 2S-6981 co-perfusion and continued during 
washout until it reached a stable plateau of -0.16±0.24% (p<O.OI; n=4) of 
baseline fEPSP slope within approximately 18 minutes of the depression 
beginning. The application of the competitive, non-selective NMDA 
receptor antagonist 2-APS SOf.lM significantly reversed the depression of 
fEPSP slope back to the level previously seen with NMDA alone (p<O.OI; 
n=4). Again, during the washout of 2-APS the depression reasserted itself 
within approximately 18 minutes to O.80±O.29% (p<O.OOI; n=4). At the 
end of the experiment and with the washout of the NMDA, the fEPSP 
returned to a level not significantly different from the baseline responses 
although it was apparent that the level and duration ofNMDA agonism had 
had a deleterious effect upon the response size. The rate of onset of effect 
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was quicker with NMDA 7.5!J.M (18 minutes) than with NMDA 4!J.M (30 
minutes) perhaps reflecting the increased rate of binding with increased 
concentration of NMDA as previously reported with glutamate (Mutel et 
al., 1998) and with ifenprodil (Grimwood et al., 2000). Figure 14 shows a 
concentration-response curve of the effect of NMDA concentrations and 
the degree to which they are potentiated to under the influence of Ro 25-
6981 3 !J.M. This shows a shift to the left of the NMDA concentration-
response curve after the application of Ro 25-6981. The concentration 
required to elicit a 50% depression of fEPSP slope changed from 1.7!-lM 
with NMDA alone to 8.6!-lM under the influence ofRo 25-6981. 
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Figure 11. Effect of Ro 25-6981 on the continuous application of NMDA 4IJM 
and its reversal by 2-AP5. 
4IJM NMDA caused a slight depression in the fEPSP slope (c). The co-
application of 3IJM Ro 25-6981 increased this response; the increase occurred 
slowly during Ro 25-6981 washout into a stable plateau, (1) fEPSP slope of 
33.84±O.32% (p<O.001; n=5) compared with the baseline. The competitive 
NMDA receptor antagonist 2-AP5 (50IJM) reversed the depression (2) (p<O.001; 
n=5). During the washout of 2-AP5, the potentiated response to NMDA re-
asserted itself (p<O.001; n=5), but recovered to baseline values upon removing 
the NMDA. Each point shows the mean±s.e.m. for n=5 experiments. 
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Figure 12. Effect of NMDA 4J..lM and Ro 25-6981 on paired-pulse interactions. 
This graph summarises paired-pulse interactions at interstimulus intervals of 
10 ms, 20 ms and 50 ms, corresponding to points (c), (1) and (2) in figure 11. 
The results demonstrate a significant enhancement of paired-pulse interactions 
during the trough of the depression caused by Ro 25-6981 and NMDA (1) 
(10 ms p<0.001, 20 ms p<0.001, 50 ms p<0.001, n=5) compared with baseline 
responses (c). These changes were reversed by 2-AP5 (2). Each point shows 
the mean±s.e.m. for n=5 experiments 
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Figure 13. Effect of Ro 25-6981 on the continuous application of NMDA 7.51JM 
and its reversal by 2-AP5. 
7.51JM NMDA caused a modest (64.6±10.4%; n.s. n=4) depression of the 
fEPSP slope. The co-application of 3IJM Ro 25-6981 increased this response; 
the increase occurred slowly during Ro 25-6981 washout into a stable plateau 
fEPSP slope of -O.16±O.24% (p<O.01; n=4) compared with the baseline. The 
competitive NMDA receptor antagonist 2-AP5 (50IJM) reversed the depression 
(p<O.01; n=4). During the washout of 2-AP5, the potentiated response to 
NMDA re-asserted itself (p<O.001; n=4), but recovered to baseline values upon 
removing the NMDA. Each point shows the mean±s.e.m. for n=4 experiments. 
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Figure 14. The concentration-response curve of NMDA alone and after 
Ro 25-6981. 
Graph summarising the concentration-response curves for responses to NMDA 
in the presence and absence of 3IJM Ro 25-6981, and showing the marked 
leftward shift produced by the combination. NMDA alone (1, 4, 7.5, 10 and 
20/-lM) and Ro 25-6981 potentiated responses to NMDA (0.1, 1, 4, 7.5 and 
10/-lM). The concentration eliciting a 50% depression of fEPSP slope changes 
from 8.61JM for NMDA alone to 1.71JM under the influence of Ro 25-6981. Each 
point shows the mean±s.e.m. 
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2-APS is a competitive antagonist at the NMDA receptor's glutamate 
binding site, in order to test that this was not a compounding factor in the 
blockade of the effect of Ro 2S-698l the non-competitive, open channel 
blocker dizocilpine (MK 801) was used to antagonise the NMDA receptor 
during the co-application of Ro 2S-698l and NMDA. The application of 
NMDA 4~M caused a small, stable depression of fEPSP slope that was 
reversed by the application of MK 801 10~M to baseline response size. 
The perfusion of Ro 2S-6981 3 ~M had no effect upon the fEPSP slope and 
during the washout of MK 801 the response size remained at baseline 
levels (figure IS). However, the non-competitive antagonism provided by 
MK 801 was not washed out of the slice over the time-period recorded 
from and this is a likely reason for the lack of any depression observed. 
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Figure 15. Effect of 4~M NMDA and Ro 25-6981 in the presence of MK 801 on 
fEPSP slope. 
Plot showing the effect of 1 O~M MK 801 applied throughout the combined 
application of 4~M NMDA and 3~M Ro 25-6981. An initial, small depression 
(approximately 5%) produced by NMDA was blocked by 10~M MK 801. This 
prevents the development of a potentiated response to NMDA plus Ro 25-6981 
even after the washout of MK 801. Each point is the mean±s.e.m. for n=3. 
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Having previously demonstrated that the Ro 25-6981-mediated potentiation 
of responses to NMDA was transiently reversible by applying 2-AP5 50~M 
this study investigated whether, by applying this competitive antagonist 
before, during and after Ro 25-6981, the induction of the depression of 
fEPSP slope could be prevented. As shown in figure 16 the application of 
NMDA 4~M produced a slight, stable depression of the fEPSP slope that 
was reversed to above the baseline levels by the subsequent application of 
2-AP5. The co-application ofRo 25-6981 3~M had no further effect upon 
the fEPSP response, 2-AP5 preventing the depression normally elicited. 
However, as 2-AP5 was washed out the depression of fEPSP slope 
developed rapidly to 14.06±5.09% of baseline fEPSP slope (p=0.0178, 
n=4) within approximately 20 minutes of it starting to reduce. The gradient 
of the development of this depression was similar to that seen with 2-AP5 
washout in figure 11 and 13; i.e. a depression that is linear and rate-
dependent upon the washout of 2-AP5. The gradient was dissimilar to the 
Ro 25-69811NMDA 4~ gradient of figure 11, which is rate-dependent on 
the effect initiated by Ro 25-6981, which is a slower developing effect 
(approximately 30 minutes). Therefore, the effect of Ro 25-6981 would 
seem to have already been realized during 2-AP5 co-perfusion suggesting 
that it does not require NMDA receptor activation. The difference in these 
gradients may be explained by the binding of Ro 25-6981 having already 
taken place during 2-AP5 perfusion; 2-AP5 was able to suppress the NR2A 
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activation-dependent expression of its effect but not the binding of Ro 25-
6981 to its unique site on the NR2B subunit and the mechanism it puts into 
effect to produce the enhanced depression of fEPSP slope. 
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Figure 16. Effect of 2-AP5 continuously bath-applied during the application of 
4jJM NMDA and Ro 25-6981 on fEPSP slope. 
A plot showing the effect of 50jJM 2-AP5 applied throughout the combined 
application of 4jJM NMDA and 3jJM Ro 25-6981. An initial, small depression 
(approximately 5%) produced by NMDA was blocked by 50jJM 2-AP5. Despite 
this, the application of 2-AP5 did not prevent the development of a potentiated 
response to NMDA plus Ro 25-6981, which appeared after washout of the 2-
AP5 and persisted until the NMDA was removed. Each point is the 
mean±s.e.m. for n=4 experiments. 
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PEAQX 
The bath application of NMDA in the adult rat hippocampus will activate 
NMDA receptors containing NR2A, NR2B and NR2D subunits. In view of 
the potentiating activity produced when the NR2B element to the action of 
NMDA was blocked by Ro 25-6981, the putative NR2A subunit antagonist 
PEAQX was used to investigate the residual response to NMDA. NMDA 
4f.lM was continuously bath-applied producing a small, stable depression of 
fEPSP slope (figure 17). The co-perfusion of 3f.lM Ro 25-6981 
transformed this into a large depression to 31.90±1.0 1 % of the baseline 
fEPSP slope (p<0.05, n=3) that developed over approximately 30 minutes. 
It was then reversed by the application of PEAQX 0.1 f.lM back to baseline 
fEPSP responses. The rate of washout of PEAQX was initially rapid but 
after 8 minutes, it slowed to such an extent that it still did not completely 
washout for at least 2 hours. These experiments were therefore concluded 
before the depression might be observed to fully re-establish. 
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Figure 17. Effect of NMDA, Ro 25-6981 and PEAQX on fEPSP slope. 
This plot shows the interaction of NMDA, Ro 25-6981 and PEAQX. 4iJM NMDA 
produces a small, stable depression, but co-perfusion of 3iJM Ro 25-6981 
transforms this into a large depression that reaches 31.90±1.01 % of the 
baseline fEPSP slope (p<0.05, n=3). This depression was reversed by 0.1 iJM 
PEAQX. The partial washout of PEAQX stabilised after 8 minutes but does not 
completely wash out for at least two hours. The experiment was therefore 
terminated before the depression was fully re-established. Each point is the 
mean±s.e.m. for n=3 experiments. 
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Protein phosphorylation 
The phosphorylation state of the NMDA receptor and many other cellular 
proteins determines their activity and function (Smart, 1997). This study 
next investigated the involvement of protein kinases and protein 
phosphatases on the Ro 25-6981 effect. 
Staurosporine (STA) is a broad-spectrum protein kinase inhibitor, enzymes 
inhibited include: PKC (ICso=3nM), PKA (ICso=7nM), tyrosine protein 
kinase (ICso=6nM) and CaMKII (ICso=20nM) (Tamaoki et al., 1986; 
Ruegg & Burgess, 1989; Yanagihara et al., 1991). As shown in figure 18 
the initial 10-minute application ofNMDA 4~M caused a small depression 
of the fEPSP slope, staurosporine lOOnM was continuously bath-applied 
and had no effect upon baseline fEPSP slope or the depression produced by 
a further 10-minute application ofNMDA 4~M. The application ofRo 25-
6981 3~M and the subsequent application ofNMDA produced a significant 
depression of fEPSP slope to 17.66±lO.83% (p<O.Ol, n=3) compared to 
baseline responses. After washout, a final application of NMDA 4~M 
produced another significant depression of fEPSP slope to 1.77±O.87% 
(p<O.OOl, n=3) compared to baseline responses (Figure 18). Therefore, 
staurosporine was unable to prevent the potentiation of responses to 
NMDA 4~M by Ro 25-6981. 
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The first phosphatase inhibitor investigated was okadaic acid (OA), a 
potent inhibitor of the serine/threonine protein phosphatases types 1 and 2A 
(PP1 and PP2A) (Bia10jan & Takai, 1988). The continuous application of 
NMDA 4~M elicited a small, stable depression of fEPSP slope. The 
addition of okadaic acid before, during and after the co-application of Ro 
25-6981 3 ~M was unable to prevent the development of a significant 
depression of the fEPSP slope to 1.56±0.3l % (p<O.OOl, n=4). 
Interestingly, upon washout the fEPSP slope recovered to an average of 
156.5±14.62% (p<0.05, n=4) of baseline responses, a significant LTP of 
responses that was stable (figure 19). This LTP-inducing effect was not 
investigated further at this time. 
Cyc1osporin A (CyA) , a widely used serine/threonine Ca2+/calmodulin-
dependent phosphatase 2B (calcineurin) inhibitor, was used next. The 
continuous bath-application ofNMDA 4~M again produced a slight, stable 
depression of fEPSP slope. The application of 1 ~M cyc1osporin A had no 
significant effect on the baseline fEPSP slope but it was able to prevent the 
anticipated enhancement of the NMDA 4~M-mediated depression of 
fEPSP slope previously seen after the application of Ro 25-6981 3 ~M 
(figure 20). Interestingly the baseline fEPSP returned to values that were 
significantly potentiated (132±0.81 %, p<0.05, n=4) compared to baseline 
responses. The application of cyc1osporin A prevented the depression of 
fEPSP slope seen with both the control group and the experiments using 
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okadaic acid and staurosporine, which were unable to inhibit the 
development of the depression. Interestingly, the magnitude of the 
depression of fEPSP slope was significantly greater than the control group 
for both okadaic acid and staurosporine (figure 21). 
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Figure 18. Action of staurosporine upon the effect of the co-application of 4~M 
NMDA and Ro 25-6981 on fEPSP slope. 
Plot showing repeated applications of NMDA 4~M produced a small depression 
of fEPSP slope that was not prevented by the co-application of 100nM 
staurosporine. The co-application of staurosporine was also not able to prevent 
the enhancement of NMDA responses by Ro 25-6981 3~M which produced a 
significant depression of the fEPSP slope to 17.66±10.83% (p<O.01). Each 
point shows the mean±s.e.m. for n=3 experiments. 
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Figure 19. Action of okadaic acid upon the effect of the co-application of 4IJM 
NMDA and Ro 25-6981 on fEPSP slope. 
Plot showing that the continuous application of NMDA 4IJM produced a small 
depression of fEPSP slope. The co-application of staurosporine before, during 
and after Ro 25-6981 was not able to prevent the enhancement of NMDA 
responses by Ro 25-6981 3IJM which produced a significant depression of the 
fEPSP slope to 1.56±O.31 % (p<O.001, n=4). Each point shows the 
mean±s.e.m. for n=4 experiments. 
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Figure 20. Prevention by cyclosporin A of the effect of the co-application of 
4\-1M NMDA and Ro 25-6981 on fEPSP slope. 
Plot showing the effect of 1 \-1M cyclosporin A (CyA) upon the Ro 25-6981 
potentiation of NMDA responses. 4\-1M NMDA produced a slight, non-significant 
depression of fEPSP slope; the application of CyA had no significant effect on 
this but prevented the enhancement of the NMDA response by 3\-1M Ro 25-
6981. Each point shows the mean±s.e.m. for n=4 experiments 
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Figure 21. Column bar graph summary of phosphorylation modulators. 
This histogram summarises the depression caused by the co-application of 4!JM 
NMDA and 3!JM Ro 2S-6981 under control conditions (figure 11, n=4) and with 
the co-perfusion of 1!JM cyclosporin A (CyA) (figure 20, n=4), SOnM okadaic 
acid (OA) (figure 19, n=4) and 100nM staurosporine (STA) (figure 18, n=3). 
Cyclosporin A prevented the depression of the fEPSP slope induced by NMDA 
in the control group (p<0.001). However, okadaic acid and staurosporine 
increased the magnitude of the depression (both p<0.01). 
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Protein synthesis 
In view of the latency of onset, the long-lasting effect of Ro 25-6981, and 
the involvement of protein phosphorylation the question arose of whether 
any permanent change was required and induced of new protein synthesis. 
To investigate this possibility anisomycin, a widely used reversible 
translation inhibitor was used (GroHman, 1967). The application of 
NMDA 4~M produced a small, stable depression of fEPSP slope. The 
continuous application of anisomycin 30~M had no significant effect upon 
the fEPSP slope nor was it able to interfere with the subsequent NMDA 
and Ro 25-6981-mediated depression of fEPSP slope to 10.65±O.3628% 
(p=O.0128, n=4)(figure 22). 
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Figure 22. Effect of anisomycin on the Ro 25-6981/NMDA effect upon fEPSP 
slope. 
Plot showing that 30jJM anisomycin was unable to prevent the development of 
the Ro 25-6981-mediated enhancement of NMDA responses (p=O.0128, n=4). 
Each point shows the mean±s.e.m. for n=4 experiments. 
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Discussion 
Applications of NMDA produced a concentration dependent depression of 
evoked fEPSP slope that was associated with an enhancement of paired-
pulse ratios at all interstimulus intervals. The fEPSP under normal 0.05Hz 
stimulation is predominantly a reflection of the fast kinetics of the AMP A 
receptors which underlie this recording, with fast rise times (10-90% rise 
time of ~400!ls) and fast decay time constant (~1.3ms). The NMDA 
component, in contrast, has slow kinetics with a slow rise time (~9ms) and 
a slow mean decay time constant (~52ms) (Gibb et al., 1994). Schaffer 
collateral inputs onto CAl neurones elicit fEPSPs where the NMDA 
receptors contribute only very a small component (~3%) (Arrigoni & 
Greene, 2004), principally as a result of the magnesium block of the 
channel at resting membrane potentials. At these negative membrane 
potentials, the magnesium ion blocks the ion channel in a voltage-
dependent non-competitive manner. The depolarisation induced by a 
single fEPSP is not sufficient to overcome the threshold leading to NMDA 
receptor activation because the membrane potential does not reach a 
sufficient level to expel the magnesium ion. However, repetitive activation 
of the synapse such as that seen in HFS and LFS stimulation protocols to 
induce LTP and LTD produces a non-linear summating effect which 
overcomes this threshold and leads to the activation of the NMDA 
receptors. It is apparent from current-voltage plots for NMDA-induced 
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conductances that even at -90m V, although the NMDA current is very 
small it is never entirely prevented by magnesium block (Mayer et a/., 
1984; Nowak et at., 1984). The bath application of NMDA receptor 
agonists will lead to the activation of synaptic and extrasynaptic NMDA 
receptors which will result in large conductance through their SOpS 
channels over longer time periods than that seen with AMP A receptors, 
producing a regenerative feedback that leads to the unblocking of NMDA 
receptors and their activation. This conductance then leads to the 
depolarisation of the cells recorded from and the subsequent depolarisation 
block of excitatory synaptic transmission, manifested as a loss of the fEPSP 
slope. The washout of NMDA agonist allows the neurones to rebuild the 
ionic gradients that underlie the membrane potential and the fEPSP 
response recovers. The application of NMDA agonists which leads to this 
depolarisation will also lead to the activation of GABAA and GABAB 
receptors responsible for fast and slow components of feed-forward and 
feedback inhibitory transmission. Although this study did not address the 
contribution of these effects on the changes in the depression of fEPSP 
slope or on paired-pulse interactions previous investigations found that 
GABA, bath-applied to the hippocampal slice, elicited no inhibition of the 
fEPSP slope or altered the paired-pulse interactions in concentrations up to 
lmM (unpublished observations). This suggested that the contribution of 
additional GABA release in this preparation is limited or already saturated 
by concentrations of GABA released in response to afferent stimulation. 
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Ro 25-6981 has been described as a selective antagonist at the NR2B 
subunit of the NMDA receptor. However, the previous work was carried 
out deliberately on immature tissue or cloned receptors overexpressing the 
NR2B subunit and not in adult tissues expressing mature NMDA receptors. 
When tested on the intrinsic neuronal circuitry of the adult hippocampal 
slice Ro 25-6981 unexpectedly potentiated NMDA receptor activation at all 
concentrations of NMDA tested and showed no inhibition of NMDA 
responses. The increased depression of fEPSP slope was generated through 
NR2A subunit-containing receptors, since the potentiated response could 
be blocked selectively by PEAQX. Furthermore, this enhancement 
appeared to have a presynaptic component, since the paired-pulse ratios 
were significantly enhanced during potentiated responses to NMDA at 
concentrations that previously showed no such change from baseline 
responses. It is widely recognised that a loss of paired-pulse inhibition and 
an increase of paired-pulse facilitation represents a presynaptic action of 
the test agents. Although it does not follow that postsynaptic effects cannot 
influence the appearance of PPD and PPF in field recordings (Seabrook et 
a!., 1999). Additionally, evidence from intracellular recordings of the 
enhancement of NMDA responses by Ro 25-6981 suggests that this 
phenomenon has a predominantly postsynaptic locus. The presynaptic 
element of responses to NMDA suggested in this study may be mediated 
via NR2A or NR2A1NR2B subunit-containing receptors. This is consistent 
with evidence for the existence of presynaptic NMDA receptors, which 
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may be responsible for changes in presynaptic release probability and the 
changes in paired-pulse interactions described here. 
The most parsimonious explanation of the present results would be that the 
NR2B subunits exert a tonic inhibitory restraint on the activation of NR2A 
subunit-containing NMDA receptors. Blockade of the NR2B subunits then 
results in disinhibition of NR2A subunit-containing receptors, which 
become the primary effectors of the increased response to NMDA. This 
would explain both the potentiating effect of Ro 25-6981 and the blockade 
of the potentiated responses by PEAQX. It is not possible to conclude 
from the present data whether this inhibitory subunit interaction occurs 
between subunits within single heterotrimeric NR11NR2A1NR2B receptors 
or between discrete heterodimeric receptors containing exclusively 
NR11NR2A and NR1INR2B subunits. Additionally, the interaction may be 
between receptor populations located at different sites interacting by way 
of intracellular or retrograde messengers. 
These results are partially consistent with reports that ifenprodil and Ro 25-
6981 caused small inward currents produced by NMDA 1/J-M to be 
potentiated, while larger currents produced by NMDA 100/J-M were 
markedly inhibited (Kew et at., 1996; Fischer et at., 1997). However, no 
inhibition against any concentrations of NMDA in the intact neuronal 
network of the adult hippocampal slice was observed. This is most simply 
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explained by the very different expressIOn of subunits and their 
phosphorylation within cloned receptor constructs, immature tissues and 
with the mature tissue used in this study but merits further investigation. 
It also appears from the data in this study that the interaction between 
NR2B and NR2A subunits was not prevented by inhibitors of protein 
kinases or the serine/threonine protein phosphatases types 1 and 2A (PP 1 
and PP2A) (Bialojan & Takai, 1988). A finding consistent with our later 
observation that Ro 25-6981 was unable to block LTP induction, which 
requires the activation of protein kinases (Bliss & Collingridge, 1993). 
Although the interaction between NR2B and NR2A subunit-containing 
receptors was not prevented by the broad-spectrum protein kinase inhibitor 
staurosporine, it is nevertheless likely that constitutively active kinases are 
essential to phosphorylate the unknown moiety to maintain the inhibitory 
restraint described. The subunit interaction does appear to involve 
Ca2+/calmodulin-dependent phosphatase 2B (calcineurin), since it was 
prevented by cyclosporin A. Ca1cineurin has previously been shown to 
enhance both the presynaptic release of glutamate and postsynaptic 
responsiveness to it (Yakel, 1997) partly by altering channel gating 
properties and promoting desensitisation in cultured hippocampal neurons 
(Lieberman & Mody, 1994; Nichols et ai., 1994; Sihra et ai., 1995; Tong et 
ai., 1995; Victor et ai., 1995). Furthermore, the calcineurin inhibitors 
cyclosporin A and FK506 are able to prevent the induction of LTD 
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(Mulkey et at., 1994; Hodgkiss & Kelly, 1995). Interestingly, it has been 
reported that calmodulin-dependent inhibition of NMDA receptors will 
reduce the amplitude and time course of excitatory synaptic currents in 12-
day-old rat hippocampal NMDA receptors (Rycroft & Gibb, 2002). NR2 
subunits, unlike NRI subunits, are known to be highly phosphorylated 
under basal conditions (Hall & Soderling, 1997), therefore the 
phosphorylation step described could be acting directly upon the NR2A 
and/or the NR2B subunit to produce the enhancement of responses to 
NMDA. It is however possible that the phosphorylation site is elsewhere 
on the NMDA receptor complex, which has been reported from proteomic 
analysis to associate with at least 77 proteins (Husi et al., 2000) e.g. NRl, 
PSD-95, SAP 102, or at a non-NMDA site. 
The present work also reveals that the potentiating effect of Ro 25-6981 is 
not dependent upon new protein synthesis, although it is expected that 
relevant proteins are constitutively present. The reason for the slow onset 
and apparently irreversible nature of the enhancement effect remains 
unclear. It may be due for example to the Ro 25-6981 binding irreversibly, 
to a persistent modification of the NR2B, NR2A or NRI subunit that is 
then independent of Ro 25-6981 binding, to an irreversible uncoupling of 
the NR2B subunit from NR2A or to a change in NMDA receptor functional 
expression. Radiolabelled forms of Ro 25-6981 are unavailable at this time 
to investigate the possibility of it binding irreversibly to the NR2B subunit. 
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Chapter 4. The NMDA subunit specificity of L TP 
Introduction 
It is widely accepted that a persistent change in synaptic strength is the 
cellular basis of learning and memory (Alkon & Nelson, 1990; Kandel, 
1997). Both long-term potentiation (LTP) and long-term depression (LTD) 
have now been shown to fulfil three out of the four criteria that are required 
to verify that they are both 'necessary and sufficient for the information 
storage underlying the type of memory mediated by the brain area in which 
that plasticity is observed'. Alterations in synaptic strength are detectable 
after learning, interfering with the induction and expression mechanisms 
results in concurrent interference in learning, and altering the pattern of 
synaptic weights after learning affects the ability of animals to remember a 
previously learned experience. The, unfulfilled, fourth criterion is 
mimicry, where an implanted pattern of synaptic weights generates in the 
animal the behaviour of a specific recalled memory (Moser et aI., 1998). 
LTP, first reported in the dentate gyrus (Lomo, 1966; Bliss & Lomo, 1973), 
has since been demonstrated in all three excitatory pathways in the 
hippocampus (Schwartzkroin & Wester, 1975; Alger & Teyler, 1976) and 
elsewhere in the eNS (Kuba & Kumamoto, 1990). LTP is characterised by 
input specificity, co-operativity and associativity, leading to the proposal 
that LTP is a Hebbian process (Hebb, 1946), where the co-incident activity 
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of pre- and postsynaptic neurones is required to increase persistently 
synaptic strength. LTP was first shown to be involved in the cellular basis 
of learning and memory with experiments to block L TP in vivo coincided 
with deficits in hippocampal-dependent place navigation (Morris et aI., 
1986). LTP induction in the CAl area is NMDA receptor dependent: it is 
triggered by NMDA receptor activation and blocked by NMDA receptor 
antagonism (Collingridge et ai., 1983). AMPA receptor-mediated 
depolarisation of the postsynaptic cell during L TP induction, by high 
frequency stimulation (HFS), releases the Mg2+ block of NMDA receptors 
allowing Ca2+ to flow into the cell (Lynch et ai., 1983; Mayer et ai., 1984; 
Nowak et ai., 1984; Malinow & Miller, 1986; Wigstrom et ai., 1986). A 
large rise in Ca2+ in the postsynaptic spine sets off a cascade of events that 
results in LTP (Bliss & Collingridge, 1993). The induction of LTP is 
widely considered to be postsynaptic and the expression both pre- and 
postsynaptic (Kullmann & Nicoll, 1992; Manabe et ai., 1993). The 
maintenance of LTP is characterised by an early phase which is dependent 
on post-translational modifications and lasts for a few hours, followed by 
later phases which are dependent on de novo gene expression and protein 
synthesis that lasts for many hours (Krug et ai., 1984; Otani et ai., 1989; 
Nguyen et ai., 1994). LTP can persist for varying amounts of time 
dependent upon the induction protocol and the experimental model. It has 
recently been demonstrated that stable L TP can last for up to a year 
(Abraham et aI., 2002). 
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There is much evidence that supports a role for the NR2B subunit in 
synaptic plasticity and specifically in LTP. Increases in the expression of 
the NR2B and not of the NR2A, NR2C or NR2D subunit after L TP 
induction and the prevention of L TP induction in an NR2B knock-down 
model support a role for the NR2B subunit in the early phase of LTP 
(Thomas et al., 1994; Thomas et al., 1996). Furthermore, enhanced 
tyrosine phosphorylation of the NR2B subunit has been demonstrated after 
the induction of LTP (Rosenblum et aI., 1996; Manabe et al., 2000; 
Nakazawa et aI., 2001). LTP and LTD are bi-directional mechanisms of 
synaptic plasticity, induced by different patterns of afferent stimulation 
(Dudek & Bear, 1993). A recent investigation was made into whether 
these different patterns reflect the activation of specific subunits to produce 
either LTD or LTP. It was found that antagonists with a higher affinity for 
the NR2AIB subunits over the NR2C/D subunits produced greater 
inhibition of LTP than LTD induction (Hrabetova et aI., 2000). There are 
also reports that the NR2B subunit is associated with age-related changes 
(Magnusson, 2000), the decrease in NR2B expression with increasing age 
leading to the blockage of L TP induction and impairments in spatial 
learning performance (Clayton et aI., 2002). Potentiating the NMDA 
receptors using spermine, an endogenous polyamine, could reverse this. 
Taking advantage of the new NR2B and NR2A subunit-selective 
antagonists, Ro 25-6981 and PEAQX, this investigation sought to 
determine the subunit specificity ofNMDA-dependent LTP induction. 
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Results 
L TP was induced by high frequency stimulation (3 identical trains of 1 
second stimulation bursts at 100Hz 10 minutes apart; HFS). This produced 
an enhancement of fEPSP slope to 197.9±16.4% (p<0.001, n=6) that 
persisted steadily for 140 minutes from the start of the induction protocol 
(figure 23 and 24). 
To demonstrate that the LTP induced by HFS was NMDA receptor-
dependent 50)lM 2-AP5 was applied during the induction protocol and 
prevented LTP induction (figure 25). PEAQX O.l)lM was then used, which 
had previously been seen in chapter 3 to block NMDA responses in an 
analogous manner to 2-AP5. The perfusion of this NR2A antagonist also 
prevented the induction of LTP (figure 26). Finally, the NR2B antagonist 
Ro 25-6981 was used but it was unable to prevent the induction of LTP to 
170.4±15.7% (p<O.Ol, n=6) of baseline fEPSP slope, which was less than 
control HFS induced LTP but not significantly so (figure 27). 
This result clearly demonstrates that the NR2A subunit, and not the NR2B 
subunit, is critically required for the induction of NMDA-dependent LTP 
(figure 28). 
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Figure 23. Effect of high frequency stimulation on fEPSP slope. 
1 
~O 
Plot showing L TP induced by three trains of stimuli using 100 pulses at 100 Hz, 
ten minutes apart (HFS) at 20, 30 and 40 minute time points, producing a 
persistent enhancement of the fEPSP slope to 197.9±16.4% of the control size 
(p<0.001, n=6). Each point shows the mean±s.e.m. for n=6 experiments. 
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Figure 24. Representative fEPSPs demonstrating L TP. 
Illustrating baseline responses (c) and potentiated responses (1) as a result of 
L TP induction; pOints correspond to figure 23. 
117 
(1) 
c. 
o 
-tn 
a.. 
en 
a.. 
w 
..... 
(1) 
c: 
.-
-(1) 
tn 
ca 
.c 
..... 
o 
.H 100Hz 
stim u lation of 
1 second 
duration. 
2-AP5 50J.lM 
100~ 
75 
50 
?fl. 25 
O+-------~---------~------~-------o 20 40 60 
time (mins) 
Figure 25. Blockade of NMDA-dependent L TP induction by 2-AP5. 
Plot showing the perfusion of 2-AP5 50flM during the HFS induction protocol for 
L TP which prevented the induction of L TP, n=3. Each point shows the 
mean±s.e.m. for n=3 experiments. 
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Figure 26. Blockade of NMDA-dependent L TP induction by PEAOX. 
Plot showing the effect of PEAOX 0.1 J.lM upon the induction of L TP. The 
perfusion of PEAOX prevented the induction of L TP. Each point shows the 
mean±s.e.m. for n=4 experiments. 
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Figure 27. Effect of Ro 25-6981 on NMDA-dependent L TP induction. 
Plot showing that the application of 3f-lM Ro 25-6981 during the HFS-L TP 
induction protocol was unable to prevent the induction of a significant L TP 
(170.4±15.7% (p<O.01, n=6) of baseline fEPSP slope. Each point shows the 
mean±s.e.m. for n=6 experiments. 
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Figure 28. Role of NR2A and NR2B subunits in long-term potentiation. 
Histogram showing L TP induction by high frequency stimulation (HFS, three 
stimulation trains of 100 pulses at 100 Hz, ten minutes apart). Bath application 
of either SO\-lM 2-APS or 0.1 \-1M PEAQX prevented the induction of LTP, 
whereas 3IJM Ro 2S-6981 did not, reducing LTP to 170.4±1S.7% (p<O.01, n=6) 
of baseline fEPSP slope. This was not significantly less than L TP in the 
absence of drugs (p=0.2S26, n=6), but was significantly greater than the original 
fEPSP baseline slope (**p<0.01, n=6). 
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Discussion 
The present study has shown that NMDA receptor-dependent LTP 
induction is critically dependent upon the NR2A subunit-containing 
receptor activation and not the NR2B subunit in the Schaffer collateral-
CAl synapse. This result is consistent with a recent report that LTP is 
associated with the rapid surface expression of postsynaptic NR2A subunit-
containing NMDA receptors (Grosshans et aI., 2002). Additionally, whilst 
Ro 25-6981 does not block the induction of LTP, the LTP induced was 
marginally reduced consistent with a recent report (Kohr et aI., 2003). 
Several reports have now been published investigating the subunit 
selectivity ofLTP and LTD (Sjostrom et ai., 2003; Liu et ai., 2004; Massey 
et ai., 2004; Mallon et aI., 2005). Liu and colleagues reported that at 
hippocampal CAl synapses of 3-4 week old rats LTP was blocked by 
PEAQX. Furthermore, using an LTP protocol pairing Schaffer collateral 
stimulation with postsynaptic depolarisation under whole-cell recording 
conditions LTP could be blocked by PEAQX and LTD was induced. The 
induction of LTD has been reported to be blocked by NR2B antagonists, 
including Ro 25-6981 and ifenprodil (Sjostrom et aI., 2003; Liu et ai., 
2004; Massey et aI., 2004). However the investigation of LTD in this 
study was prevented because of the difficulty in induction of LTD in adult 
animals, in agreement with reports by other laboratories (Kemp & Bashir, 
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2001). Massey and colleagues reported that the induction of L TP and 
depotentiation in the perirhinal cortex of 7 -12 week old rat was blocked by 
PEAQX. They also found that LTD was difficult to induce but that 
blockade of glutamate uptake, which led to the activation of postsynaptic, 
extrasynaptic NR1/NR2B receptors, overcame this obstacle. This allowed 
the induction of LTD, which could also be prevented by Ro 25-6981, the 
NR2B antagonist. However, the distribution of NMDA receptor subunits 
varies widely developmentally and between brain regions and synaptic 
pathways (Otmakhova et a!., 2002; Arrigoni & Greene, 2004). Therefore, 
different local conditions can regulate the sensitivity and characteristics of 
synaptic plasticity to different NR2 subunits. It has also been reported that 
LTP is sensitive to NR2B antagonists in the young Schaffer collateral-CAl 
synapse (R. Malenka, personal communication), visual cortex (Yoshimura 
et al., 2003), amygdala (T. Sigurdsson, personal communication) and the 
hippocampal commissural-CA3 synapse (Ito et al., 2000). The NR2B 
subunit, unlike the NR2A subunit-containing receptors or AMPA receptors, 
seem to be of particular importance in regulating learning and memory and 
have recently been reported to be differentially distributed in the left-right 
asymmetry of the brain, which has important implications for higher order 
functions (Kawakami et al., 2003; Shinohara et al., 2003). 
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Chapter 5. The NR2A & NR2B subunit-selectivity 
of homoquinolinic acid 
Introduction 
The tryptophan metabolite, quinolinic acid (QA), has been recognized for 
many years to be a weak, endogenous NMDA receptor agonist (Stone & 
Perkins, 1981; Stone, 1984; 1993). Shortly after its discovery, a study of 
structure-activity relationships among a series of related compounds 
revealed that a close analogue, homoquinolinic acid (HQA), had a potent 
excitatory activity. Indeed, HQA appeared to be between 10 and 100-fold 
more potent at activating glutamate receptors (Stone, 1984). 
Autoradiographical and electrophysiological studies have recently been 
undertaken on native and recombinant receptors to evaluate the subunit-
specificity of HQA. It has been reported from electrophysiological studies 
that HQA is a potent NMDA receptor agonist that has a higher affinity for 
Xenopus oocytes expressing NR2A and NR2B subunit-containing 
receptors, compared to NR2C and NR2D subunit-containing receptors 
(Buller & Monaghan, 1997). A recent study also found that HQA had an 
approximately 2-fold higher affinity for NR1a/NR2B and 
NR1 a/NR2A/NR2B receptors compared to NR1 a/NR2A receptors (EC50 
13.8, 9.04 and 25.2JlM, respectively). Yet showed greater intrinsic activity 
for NR1 a/NR2A and NR1 a/NR2A1NR2B compared to NR1 a/NR2B 
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transfected receptors (compared to glutamate responses (100%), 148±15, 
125±5.6 and 93.3±4%, respectively) (Grimwood et al., 2002). In 
autoradiographical studies, it has been observed that 3[H]-homoquinolinic 
acid selectively radiolabels a subpopulation of NMDA receptors in rat 
brain that is consistent with the distribution of the NR2B subunit and 
clearly dissimilar to NR2C and NR2D subunit distribution (Buller et al., 
1994; De Carvalho et al., 1996; Brown et al., 1998), although there are 
contradictory reports where HQA was not as highly specific for NR2B-
containing receptors (Grimwood et al., 2002). In radioligand binding 
studies 3[H]-HQA also bound to a novel binding site from which it was not 
displaced by NMDA or glutamate but was displaced by 2-carboxy-3-
carboxymethylquinoline (CCMQ), a HQA derivative (Brown et ai., 1998; 
Grimwood et al., 2002). The identity and function of this proposed site are 
unknown. 
This investigation was designed to establish whether there was any 
evidence for this unidentified site in the generation of evoked synaptic 
potentials in the hippocampal slice. Additionally, by using an 
NR2A1NR2B subunit-containing NMDA receptor agonist (HQA) to 
investigate subunit-pharmacology in combination with NR2A and NR2B 
subunit-selective antagonists (PEAQX and Ro 25-6981) this study can 
consider the role of NR2D subunit-containing receptors on the depression 
of fEPSP slope and paired-pulse interactions. 
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Results 
HQAand QA 
In order to determine the most suitable concentrations of agonists to use 
concentration-response curves were constructed from which it was clear 
that HQA and QA gave useful depressions of approximately 50% of the 
baseline fEPSP slope at 2.5~M and l50~M respectively (figures 29-31, 34-
36). These concentrations were selected for further experiments since both 
increases and decreases of the depression of fEPSP slope could easily be 
observed. The depression elicited by the application of HQA 2.5~M and 
QA l50~M both coincided with a significant decrease of paired-pulse 
inhibition and increase of paired-pulse facilitation at all interstimulus 
intervals (HQA: 10ms p<O.Ol, 20ms p<O.OOl, 50ms p<O.OOl, n=lO; QA: 
10ms p<0.05; 20ms p<O.OOl; 50ms p<O.OOl; n=7) (figures 32,33,37,38). 
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Figure 29. The concentration-response curve of HQA. 
A plot showing concentration-response curve for homoquinolinic acid-produced 
depression of the fEPSP slope at 1, 2, 2.5, 3 and 4IJM (n = 3, 5, 8, 5 and 4, 
respectively). The concentration inducing a 50% reduction is 2.4 IJM. Each 
point shows the mean±s.e.m. 
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Figure 30. Effect of HQA 2.5f-LM on fEPSP slope. 
A plot of fEPSP slope showing that homoquinolinic acid 2.51JM caused a 
depression of normalised fEPSP slope to approximately 50% (here 45.4% ± 
8.12, p < 0.01, n = 8) relative to control responses. Each point shows the 
mean±s.e.m. for n=8 experiments. 
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Figure 31. Representative fEPSPs showing effect of 2.51JM HQA. 
fEPSPs corresponding to baseline (c) responses and during the depression 
elicited by HQA 2.51JM (1) in the time course of figure 30. 
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Figure 32. Effect of 2.51JM HQA on paired-pulse interactions. 
Shows the paired-pulse interactions of fEPSP slope at interstimulus intervals of 
10ms, 20ms and 50ms during the depression elicited by HQA 2.5~M. The 
results are presented as the interactions during baseline control responses (c), 
the effect of homoquinolinic acid 2.5~M (1) and the washout period (2) (1 Oms 
p<0.01, 20ms p<0.001, 50ms p<0.001, compared to baseline control 
responses, n=10), points correspond to the time course of figure 30. The data 
show a loss of paired-pulse inhibition at 10ms, and increased paired-pulse 
facilitation at 20 and 50ms caused by homoquinolinic acid. *P < 0.05, **P < 
0.01, ***P < 0.001. Each point shows the mean±s.e.m. for n=10 experiments 
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Figure 33. Example records of fEPSPs during paired-pulse interactions. 
During baseline recording: (a) 10ms (b) 20ms and (c) 50ms and during the 
depression elicited by HQA 2.5~M: (d) 10ms (e) 20ms and (f) 50ms. 
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Figure 34. The concentration-response curve of QA. 
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A plot showing the concentration-response curve of the fEPSP slope to 5-
minute applications of QA: 10, 50, 100, 150, 300 and 1 OOO~M (n=4, 3, 6, 8, 3, 
and 4 respectively). The concentration inducing a 50% reduction is 157.2IlM. 
Each point shows the mean±s.e.m. 
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Figure 35. Effect of 150l-lM QA on fEPSP slope. 
A plot of fEPSP slope showing that quinolinic acid 150l-lM caused a depression 
of normalised fEPSP slope to 55.7%±8.12% (p=O.0017; n=8) relative to control 
responses. Each point shows the mean±s.e.m. for n=8 experiments. 
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Figure 36. Representative fEPSPs showing the effect of QA 150\JM. 
fEPSPs corresponding to baseline (c) responses and during the depression 
elicited by QA 150\JM (1) in the time course of figure 35. 
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Figure 37. Effect of QA on paired-pulse interactions. 
Shows paired-pulse interactions of the fEPSP slope under resting conditions, 
(c), in the presence of quinolinic acid 150 !-1M (1), and during washout (2). 
Quinolinic acid caused a significant decrease of paired-pulse inhibition at 10ms, 
and a facilitation of the paired-pulse ratio at greater intervals. Points 
correspond to in the time course of figure 35. *P < 0.05, **P < 0.01, ***P < 
0.001 compared to baseline control responses. Each point shows the 
mean±s.e.m. for n=7 experiments. 
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Figure 38. Example records of fEPSPs during paired-pulse interactions. 
During baseline recording: (a) 10ms (b) 20ms and (c) 50ms and during the 
depression elicited by QA 150jJM: (d) 10ms (e) 20ms and (f) 50ms. 
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DPCPX 
Adenosine is a neuromodulator with an important role in synaptic 
transmission and neuronal excitability, inhibiting transmission via the 
activation of presynaptic Al receptors by decreasing release probability 
which enhances the paired-pulse interaction (Dunwidde, 1985; Greene, 
1991). 1,3-dipropyl-8-cyclopentyl-xanthine (DPCPX) is a potent and 
selective adenosine Al receptor antagonist (Linden, 1991). Since the 
depolarisation of excitable tissues elicits the release of adenosine, it was 
important to confirm that the depression of fEPSP slope and the associated 
changes in paired-pulse interactions were indeed directly attributable to the 
activation of NMDA receptors and not to the release of endogenous 
adenosine. 
An initial application of HQA 2.5/-lM caused a depression of baseline 
fEPSP slope to 13.13±3.88% (p<O.OOI, n=5). In the presence of DPCPX 
20nM, a concentration that selectively blocks adenosine Al receptor, the 
second application of HQA 2.5/-lM caused a similar depression to 
15.20±7.04% (p<O.OOI, n=5) compared to baseline responses (figure 39). 
During the initial HQA application the paired-pulse interactions were 
significantly enhanced at all interstimulus intervals (p<O.O 1, n=5 at all 
intervals) compared to baseline control responses. The co-application of 
DPCPX during the second application of HQA produced an exactly similar 
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effect (p<0.01, n=5 at all intervals) compared to baseline control responses 
(figure 40). This suggests that the presynaptic element of the depression of 
fEPSP slope is not dependent upon the activation of presynaptic adenosine 
Al receptors. 
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Figure 39. Effect of DPCPX upon HQA-evoked depression of fEPSP slope. 
A plot of fEPSP slope showing the depression of baseline (c) fEPSP slope 
caused by HQA 2.5/lM alone (1), and in the presence of DPCPX 20nM (2). 
Each point shows the mean±s.e.m. for n=5 experiments. 
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Figure 40. Effect of HQA and DPCPX upon paired-pulse interactions. 
1 
2 
c 
Showing the paired-pulse interactions of fEPSP slope at interstimulus inteNals 
of 10ms, 20ms and 50ms; the results are presented as HQA 2.5~M (1) (p<0.01, 
n=5 at all inteNals) and HQA 2.5~M in the presence of DPCPX 20nM (2) 
(p<0.01, n=5 at all inteNals) both produced significant enhancements of paired-
pulse interactions compared with baseline control responses (c). Each point 
shows the mean±s.e.m. for n=5 experiments. 
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Inhibition by kynurenic acid, 2-AP5 and dizocilpine 
The broad-spectrum EAA antagonist, kynurenic acid (KYA) 100/-lM, was 
used at a concentration that selectively blocks NMDA and not AMP A or 
kainate receptors (Perkins & Stone, 1982; Stone & Burton, 1988). This 
blocked the depressant effect of both QA and HQA on the evoked tEPSP 
with no residual response that might indicate a novel binding site (figure 
41). The selective and competitive NMDA receptor antagonist 2-APS 
SO/-lM was used, which also blocked the effect of both QA lSO/-lM and 
HQA 2.S /-lM but again left no residual effect upon the evoked tEPSP 
(p<0.001 and p<O.OOl; respectively, n=4) (figure 42). 
It was thought that the concentration of HQA required to activate the novel 
binding site might be higher than that required for NMDA receptor 
activation, but that raising the agonist concentration would simply out-
compete the blockade of 2-APS. Therefore, the selective and non-
competitive NMDA receptor antagonist dizocilpine (MK 801) 10/-lM was 
used, which produces a voltage and use-dependent non-competitive 
blockade of the NMDA receptor ion-channel. This blockade allowed the 
increase by 10-fold the concentration of both QA and HQA to 1.SmM and 
2S /-lM respectively so that any novel binding site should be more strongly 
activated. The blockade of the NMDA receptor was confirmed using 
NMDA itself at 10/-lM. However, in the presence of MK 801 these high 
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concentrations of agonists still did not induce any observable changes in 
the fEPSP. Unfortunately, it was not possible to perform control responses 
to these higher concentrations of QA and HQA because, without the 
presence of the antagonist, they produced a complete and largely 
irreversible loss of the fEPSP, through excitotoxic neuronal damage (figure 
43). 
142 
lillliliiiilil!1 KYA 100~M 
QA 150~M 
• HQA2.5~M 
(U 
c.. 
0 .. 
- ~~ tn . . .... 
" , . 
c.. , . . .. . . 
en . 
c.. ~ 
· W · · · 
..... 
(U 
· · c: · . . 
. -
· 
-
· .(U · 
tn 
CO . 
.c · 
': 
..... · 
· 0 · . : 
. 
~ •• 'Ii Q ~i 
1""······· .. ··· .... ······ .. ······················ .... 1 l:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::; 
~ ~ 
o 50 100 150 200 
time (mins) 
Figure 41. Effect of kynurenic acid on QA and HQA-induced depressions of 
fEPSP slope. 
Representative plot showing the blockade by kynurenic acid 1 OO~M of the 
depression of fEPSP slope caused by QA 150~M and HQA 2.5~M. 
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Figure 42. Effect of 2-AP5 on QA and HQA on fEPSP slope. 
A plot showing the depression of fEPSP slope during the application of 
quinolinic acid 150J-LM and homoquinolinic acid 2.5J-LM and their subsequent 
inhibition by 2-AP5 50J-LM (P < 0.001 and P < 0.001; respectively). Each point 
shows the mean±s.e.m. for n=4 experiments. 
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Figure 43. Effect of MK 801 on QA and HQA on fEPSP slope. 
A plot showing the inhibition by MK 801 10llM of the depressant effect upon 
fEPSP slope by NMDA 10IlM, QA 1.5mM and HQA 251lM. Each point shows 
the mean±s.e.m. for n=4 experiments. 
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Ro 25-6981 
As illustrated in figure 44, HQA 2~M (i) and QA 100~M (1) are 
concentrations that produced small yet discernible depressions of baseline 
fEPSP slope (c). With the co-perfusion of Ro 25-6981 3~M, the same 
concentrations of QA (2) and HQA (ii) produced significant depressions of 
the fEPSP slope to 24.19±15.39% and -1.88±4.93% respectively compared 
to baseline responses (p<O.OOl and p<O.OOl respectively n=5). Ro 25-6981 
was then allowed to wash out and QA (3) and HQA (iii) were re-applied 
where a significant depression to 8.98±5.21 % and -5.59±4.04% of control 
respectively was still observed (p<O.OOl and p<O.OOl respectively n=5) 
(figure 44). It was noticed that the effect of Ro 25-6981 seemed to develop 
slowly and did not diminish during the washout phase of the experiment. It 
was also observed that paired-pulse interactions were significantly 
enhanced during the enhanced depressions of QA and HQA at all 
interstimulus intervals after the application of Ro 25-6981 compared to 
during the initial applications (QA: 10ms p<O.Ol, 20ms p<O.05, 50ms 
p<O.Ol; HQA: 10ms p<O.OOl, 20ms p<O.OOl, 50ms p<O.05, n=6; figure 45 
and 46). 
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Figure 44. Effect of Ro 25-6981 with QA and HQA on fEPSP slope. 
A plot showing the effect of QA 100IJM (1) and homoquinolinic acid 2IJM (i) 
compared to the baseline fEPSP response (c). During the co-perfusion of Ro 
25-6981 3~M, the same concentrations of QA (2) and homoquinolinic acid (ii) 
produced a significant depression to 24.19±15.39% and -1.88±4.93% of the 
fEPSP slope respectively compared to baseline responses (p<0.001 and 
p<0.001 respectively). Ro 25-6981 was then washed out for 20 minutes until 
QA (3) was re-applied and 45 minutes until homoquinolinic acid (iii) was re-
applied where a significant depression to 8.98±5.21 % and -5.59±4.04% 
respectively was observed compared to the baseline fEPSP responses 
(p<0.001 and p<0.001 respectively). Each point shows the mean±s.e.m. 
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Figure 45. Effect of Ro 25-6981 and QA on paired-pulse interactions. 
A plot showing the paired-pulse interactions at interstimulus intervals of 10ms, 
20ms and 50ms during baseline recordings (c), the initial application of QA 
100~M (1) and the second application of QA 100~M during the co-perfusion 
with Ro 25-6981 3~M (2) (10ms p<0.01, 20ms p<0.05, 50ms p<0.01, n=6). 
Points correspond to figure 44. *P < 0.05, **P < 0.01, ***P < 0.001. Each point 
shows the mean±s.e.m. for n=6 experiments. 
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Figure 46. Effect of Ro 25-6981 and HQA on paired-pulse interactions. 
Showing the paired-pulse interactions at interstimulus intervals of 10ms, 20ms 
and 50ms during baseline recordings (c), the initial application of HQA 2~M (i) 
and the second application of HQA 2~M during the co-perfusion of Ro 25-6981 
3~M (ii) (10ms p<0.001, 20ms p<0.001, 50ms p<0.05, n=6). Points correspond 
to figure 44. *P < 0.05, **P < 0.01, ***P < 0.001. Each point shows the 
mean±s.e.m. for n=6 experiments. 
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Excitotoxicity 
An application of HQA that significantly depressed the fEPSP slope was 
selected to investigate the effect of Ro 25-6981 on higher concentrations of 
NMDA receptor agonists. In previous studies of young cultured rat cortical 
neurones Ro 25-6981 had potentiated small depolarising concentrations of 
NMDA but blocked larger depolarising concentrations (Fischer et al., 
1997). A 5-minute application of HQA 4/-lM caused a maximal depression 
offEPSP slope to 6.63±3.69% (p<0.001, n=4) that reverted to near baseline 
responses upon washout. Ro 25-6981 3/-lM was co-perfused with a second 
application of 4/-lM HQA which produced a depression of fEPSP slope to 
-9.27±1.13% (p<0.001, n=4). However, this depression did not fully 
recover to baseline responses. The fEPSP slope was irreversibly reduced to 
an average 34.70±0.38% compared to baseline responses (p<0.001, n=4). 
Maximum evokable amplitudes of fEPSP slope (100%), which were taken 
as an additional measure of excitotoxic damage, were significantly reduced 
(p=O.OOll, n=4) compared to the baseline maximums recorded and they 
did not recover during the 70-minute washout phase of the experiment. 
Attempts to induce L TP at the end of the experiments also failed, again 
suggesting that irreversible excitotoxic damage had occurred (figure 47 and 
48). This specifically ruled out the induction of NMDA-receptor 
dependent LTD, which was reversible by high frequency stimulation (data 
not shown). 
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Figure 47. Effect of HQA 4J.!M and Ro 25-6981 on fEPSP slope. 
A 5-minute application of homoquinolinic acid 4J.!M elicited a reversible 
depression of baseline fEPSP slope to 6.63±3.69% (p<O.001). Ro 25-6981 
3J.!M was co-perfused and a second 5-minute application of homoquinolinic acid 
4J.!M produced a depression of fEPSP slope to -9.27±1.13% (p<O.001). 
However, the fEPSP slope did not fully recover but was significantly and 
irreversibly reduced to an average 34.70±O.38% compared to the initial baseline 
(p<O.001). Each point shows the mean±s.e.m. for n=4 experiments. 
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Figure 48. Representative fEPSP recordings showing excitotoxicity. 
During baseline recording (c) and during the irrecoverable depression (1) 
corresponding to figure 47. 
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NR2A antagonists 
HQA is reported to be a selective agonist for NR2A and NR2B subunit-
containing NMDA receptors. Using Ro 25-6981, an NR2B antagonist, to 
produce the potentiation of the depression of fEPSP slope by low 
concentrations of HQA suggests that the remaining HQA-dependent effect 
could be modulated by the remaining NR2A component of HQA activity. 
In order to test this theory several candidate NR2A selective antagonists 
including zinc, CCMQ and PEAQX were investigated (Paoletti et aI., 1997; 
Brown et ai., 1998; Auberson et ai., 2002; Grimwood et aI., 2002). 
CCMQ 
Previous autoradiographical studies found that 2-carboxy-3-
carboxymethylquinoline (CCMQ), a derivative of HQA, displaces bound 
eH]-HQA from its NMDA-insensitivenovel binding site at a concentration 
of 1mM, leaving behind a binding pattern which closely resembles the 
distribution of NR2B subunits in the rat brain (Brown et ai., 1998; 
Grimwood et ai., 2002). These results and the structural homology with 
HQA suggest that CCMQ may be able to displace HQA from the NR2A 
subunit-containing NMDA receptors thereby leaving only the NR2B 
population, acting as an NR2A-selective ligand. 
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The effect of CCMQ 0.5mM upon the HQA-induced depression of fEPSP 
slope was investigated first. As shown in figure 49 two initial applications 
of HQA 2.5 f.lM produced two similar depressions of fEPSP slope. The 
third application of HQA was co-applied with CCMQ but this had no effect 
on an identical depression of fEPSP slope. This suggests that CCMQ was 
not acting as an antagonist of the NR2A site activated by HQA. This study 
next investigated if CCMQ was an NR2A agonist and used Ro 25-6981 to 
block the NR2B subunit in order to help reveal any NR2A effect. As 
shown in figure 50 the perfusion of Ro 25-6981 alone had no effect upon 
baseline fEPSP slope but CCMQ elicited a small potentiation of the fEPSP 
slope to 108.65±1.71 % (p=0.0058, n=3). Finally, the effect of CCMQ 
upon the potentiation of HQA 2f.lM caused by Ro 25-6981 3 f.lM was 
investigated in order to address the subunit specificity of this potentiation. 
As shown in figure 51 the application of HQA 2f.lM produced little 
response but the application of Ro 25-6981 potentiated this to a significant 
depression to 14.72±10.49% (p<O.OOI, n=3) of baseline fEPSP slope, 
which was not inhibited by CCMQ. The co-perfusion of CCMQ resulted 
again in the same small but significant increase in fEPSP slope to 
124.25±2.75% (p<O.05, n=3). A third application ofHQA 20 minutes after 
the end of the perfusion of Ro 25-6981 also produced a large depression to 
7.18±3.24% (p<O.OOI, n=3) offEPSP slope. 
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Figure 49. Effect of HQA 2.5~M and CCMQ O.5mM on fEPSP slope. 
100 
A plot showing the effect of repeated 5-minute perfusions of homoquinolinic 
acid 2.5~M, that caused three consecutive depressions of the fEPSP slope. 
The co-perfusion of CCMQ O.5mM with the third perfusion of homoquinolinic 
acid had no significant effect upon the peak magnitude or duration of the 
response. Each point shows the mean±s.e.m. for n=3 experiments. 
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Figure 50. Effect of CCMQ and Ro 25-6981 on fEPSP slope. 
A plot showing the effect of 3jJM Ro 25-6981 and the subsequent co-perfusion 
of O.5mM CCMQ which produced a small potentiation of the fEPSP slope to 
108.65±1.71 % (p=O.0058). Each point shows the mean±s.e.m. for n=3 
experiments. 
156 
Q) 
Q. 
0 
-tn 
D.. 
tJ) 
D.. 
W 
'I-
Q) 
c: 
--
-Q) 
tn 
ca 
.c 
'I-
0 
~ 0 
120 
100 
80 
60 
40 
20 
0 
0 
II HQA 211M 
D Ro 25-6981 311 M 
III CCMQ 0.5 mM 
20 40 60 80 
time (mins) 
100 
Figure 51. Effect of HQA 2f.lM, Ro 25-6981 and CCMQ 0.5mM on fEPSP slope. 
Plot showing that the first application of HQA 2f.lM produced little response but 
the co-application of Ro 25-6981 potentiated a second HQA-application 
producing a significant decrease to 14.72±10.49% (p<0.001) of baseline fEPSP 
slope. The co-perfusion of CCMQ again resulted in the same small but 
significant increase in fEPSP slope to 124.25±2.75% (p<0.05). A third 
application of HQA 20 minutes after the end of the perfusion of Ro 25-6981 also 
produced a large depression to 7.18±3.24% (p<0.001) of fEPSP slope. Each 
point shows the mean±s.e.m. for n=3 experiments. 
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Zinc 
Zinc ions (Zn2+) have been reported to produce a selective and non-
competitive inhibition of the NR2A subunit-containing recombinant 
NMDA receptors, producing a voltage-independent inhibition at nanomolar 
concentrations (Paoletti et aI., 1997). As shown in figure 52 an initial 
application of HQA 2.5 JlM caused a significant depression of fEPSP slope 
to O.7±O.57% (p<O.OOl, n=4) , a second application of HQA with Zn2+ 
100nM also produced an identical depression of fEPSP slope to 2.6±2.2% 
(p<O.Ol, n=4). Thus, 100nM Zn2+ was unable to prevent the depression of 
fEPSP slope. 
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Figure 52. Effect of HQA 2.5flM and Zn2+ 100nM on fEPSP slope. 
A plot showing that the first application of HQA 2.5flM caused a significant 
depression of baseline fEPSP slope to O.7±O.57% (p<O.001). A second 
application of 2.51JM HQA with 100nM Zn2+ again produced a similar depression 
of fEPSP slope to 2.6±2.2% (p<O.01). Each point shows the mean±s.e.m. for 
n=4 experiments. 
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PEAQX 
Having been unsuccessful with CCMQ and zinc in attempts to antagonise 
the NR2A subunit, PEAQX, a novel NR2A antagonist was obtained as a 
gift from Dr Yves Auberson of Novartis Pharmaceuticals. This compound 
has l26-fold selectivity for the NMDA NRlAINR2A over the 
NRlAINR2B receptors expressed in Xenopus oocytes (ICso = l4nM and 
l800nM respectively)(Auberson et al., 2002). This investigation was 
started by constructing a concentration-response curve for the inhibitory 
effect of PEAQX upon the depression of fEPSP slope elicited by HQA 
3 ~M. This was achieved by applying 3 ~M HQA, which produced a large 
depression of the fEPSP slope, and then PEAQX was co-applied at varying 
concentrations. Subsequent co-applications of the same concentration of 
HQA were made and the degree of antagonism produced was observed 
(figures 53 and 54). From the concentration-response curve it was 
determined that using a concentration of 0.1 ~M provided the most selective 
and complete antagonism of the NR2A subunit-containing NMDA 
response. This concentration-response curve is very similar to that found 
for the effect of PEAQX on NMDA-induced currents in Xenopus oocytes 
expressing human NRlAl2A subunits (Appendix 2). 
This study also investigated paired-pulse interactions during the interaction 
of HQA and PEAQX. It was found that during the initial depression of 
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fEPSP slope caused by HQA 3 JlM the paired-pulse ratios were increased at 
all interstimulus intervals (lOms p<O.OOI, 20ms p<O.OI, 50ms p<O.OOI; 
n=6) but that during the subsequent co-application of PEAQX 0.1 JlM and 
HQA 3 JlM they remained similar to baseline responses (figure 55). 
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Figure 53. Effect of HQA and PEAQX on fEPSP slope. 
A plot showing that the control application of HQA 31lM (1) produced a 
significant depression of baseline fEPSP slope (c) to 20.44±O.59% (p=O.0019). 
The depression of fEPSP slope expected by the second application of HQA 
31lM was prevented by the co-application of PEAQX O.1j..1M (2), Each point 
shows the mean±s.e.m. for n=6 experiments. 
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Figure 54. The concentration-response curve of PEAQX on HQA-induced 
depression of fEPSP slope. 
A plot showing the concentration-response curve of the inhibitory action of 
PEAQX at concentrations of 1 nM, 5nM, 10nM, 50nM, 100nM and 500nM (n=3 
at all intervals, except n=6 for 100nM PEAQX) upon HQA 3f.lM, which normally 
caused a significant depression of fEPSP slope. A concentration of 9.23nM is 
predicted to produce a 50% inhibition of the depression elicited by HQA 31JM. 
Each point shows the mean±s.e.m. 
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Figure 55. Effect of HQA and PEAQX on paired-pulse interactions. 
c 
2 
A plot showing the paired-pulse interactions during baseline responses (c), 
which were significantly enhanced at interstimulus intervals of 10ms, 20ms and 
50ms during the first application of HQA 3~M (1) and returned to control levels 
during the blockade of the second application of HQA 3~M by PEAQX 0.11JM 
(2). Points correspond to the time-course in figure 53. Each point shows the 
mean±s.e.m. for n=6 experiments. *P < 0.05, **P < 0.01, ***P < 0.001. 
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PEAQX's inhibition of the Ro 2S-6981/HQA potentiation. 
However, of greater interest was the finding that the potentiated depression 
of fEPSP slope obtained by HQA 2~M with Ro 25-6981 3 ~M was also 
completely blocked by PEAQX 0.1~. As shown in figure 56, a 
concentration of 2~M HQA (1) initially produced a small and insignificant 
depression of the baseline fEPSP slope (c) but following the perfusion of 
Ro 25-6981 3 ~M, a second application of HQA 2~M (2) produced a 
significant depression of fEPSP slope to 37.33±4.43% (p=O.0261, n-4). 
The co-perfusion of PEAQX O.l~M prevented the depression of a third 
application of HQA 2~M (3). 
It was also observed that paired-pulse interactions during the first 
application of HQA 2~M (1) were not significantly different from baseline 
responses (c). However, after the application of Ro 25-6981 3~M, the 
second application of HQA 2~M (2) caused a significant enhancement of 
paired-pulse ratios (p<O.OOI, n=4 at all interstimulus intervals). During the 
inhibition by PEAQX O.I~M, the third application of HQA 2~M (3) saw 
paired-pulse interactions remain similar to baseline responses (figure 57). 
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Figure 56. Effect of HQA, Ro 25-6981 and PEAQX on fEPSP slope. 
A plot showing the effect of a low concentration of homoquinolinic acid 2JlM (1) 
that initially produced a small, insignificant depression of the baseline fEPSP 
slope (c). Following the perfusion of Ro 25-6981 3JlM, a second application of 
homoquinolinic acid 2JlM (2) produced a significant depression of fEPSP slope 
to 37.33±4.43% (p=O.0261). The co-perfusion of PEAQX O.1JlM, an NR2A 
selective antagonist, inhibited the depression of the third application of 
homoquinolinic acid 2JlM (3). Each point shows the mean±s.e.m. for n=4 
experiments. 
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Figure 57. Effect of HQA, Ro 25-6981 and PEAQX on paired-pulse 
interactions. 
This plot shows the paired-pulse interactions recorded during the co-perfusions 
of HQA 2/lM, Ro 25-6981 3/lM and PEAQX 0.1IJM. Points correspond to the 
time course of figure 56. Paired-pulse interactions during the first application of 
homoquinolinic acid 2/lM(1) were not significantly different from baseline 
responses (c). However, after the application of Ro 25-6981 3/lM the second 
application of homoquinolinic acid 2/lM (2) caused an enhancement of the 
paired-pulse interactions at 10ms (p<0.001), 20ms (p<0.001) and 50ms 
(p<0.001) compared to baseline interactions. During the NR2A inhibition of 
PEAQX the third application of homoquinolinic acid 2/lM (3) saw the paired-
pulse interactions return to baseline responses (n=4). Each point shows the 
mean±s.e.m. for n=4 experiments. *P < 0.05, **P < 0.01, ***P < 0.001. Points 
correspond to the time course in figure 56. 
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Protein synthesis 
In view of the latency of onset, the long-lasting effect of Ro 25-6981 and 
the involvement of a protein phosphatase signal transduction step the 
question arose of whether any new protein synthesis was required and 
induced. To investigate this possibility anisomycin 30f.lM was used, which 
has previously been shown to block the maintenance of L TP and LTD at 
this concentration and over this timescale (Grollman, 1967; Otani et at., 
1989; Manahan Vaughan et at., 2000; Karachot et at., 2001). An initial 
application of HQA 2f.lM caused a small depression to 82.68±3.l6% of 
baseline fEPSP slope. Anisomycin 30f.lM and the subsequent co-perfusion 
of Ro 25-6981 3 f.lM had no significant effect on the baseline fEPSP slope. 
A second application of HQA 2f.lM produced a large and significant 
depression of fEPSP slope to 0.91±3.0% (p=0.0152, n=4) compared to the 
initial application of HQA 2f.lM. A similar profound depression of fEPSP 
slope to 6.05±4.86% (p=0.0128, n-4) , again in comparison to the initial 
application of HQA 2f.lM, was obtained with a subsequent application of 
HQA 2f.lM (figure 58). This suggests that new protein synthesis is not 
required for the potentiation by Ro 25-6981. 
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Figure 58. Effect of HQA, Ro 25-6981 and anisomycin upon fEPSP slope. 
Plot showing that an initial application of homoquinolinic acid 2~M caused a 
small depression of baseline fEPSP slope, the perfusion of anisomycin 30~M 
and subsequent co-perfusion of Ro 25-6981 3~M had no significant effect on 
the baseline fEPSP slope. The second application of homoquinolinic acid 2~M 
produced a depression to 0.91±3.04% (p=0.0152,n=4) compared to the trough 
of the initial application of homoquinolinic acid 2~M. After washing out for 20 
minutes a further application of homoquinolinic acid 2~M caused a similar 
depression of fEPSP slope to 6.05±4.86% (p=0.0128, n=4) again in comparison 
to the trough depression of the initial application of homoquinolinic acid 2~M. 
Each point shows the mean±s.e.m. for n=4 experiments. 
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AMPA and kainate receptors 
The earlier paired-pulse data suggested that there might be a presynaptic 
component during the NMDA, HQA and QA evoked depressions of fEPSP 
slope. AMP A and kainate receptors are the main glutamatergic receptors 
responsible for basal synaptic transmission and the generation of currents 
underlying the fEPSP. AMP A and kainate were used at 100nM and 25nM 
respectively, concentrations that produced small depressions of the fEPSP 
slope. In both cases, the application of Ro 25-6981 3 ~M had no effect on 
the responses, confirming that this effect is specific to NMDA receptor 
activation (figures 59 and 60). This is consistent with the absence of effect 
of Ro 25-6981 alone upon baseline responses. 
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Figure 59. Effect of Ro 25-6981 and AMPA on fEPSP slope. 
Plot showing the effect of 100nM AMPA applied before and after the perfusion 
of 3IJM Ro 25-6981, the response to AMPA was unchanged. Each point shows 
the mean±s.e.m. for n=3 experiments. 
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Figure 60. Effect of Ro 25-6981 and KA on fEPSP slope 
100 
Plot showing the effect of 25nM kainate applied before and after the perfusion 
of 3IJM Ro 25-6981, the response to kainate was unchanged. Each point 
shows the mean±s.e.m. for n=3 experiments. 
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Discussion 
In order to expose a response to the activation by homoquinolinic acid of 
the uncharacterised binding site reported by others the non-selective EAA 
antagonist kynurenic acid, the competitive NMDA receptor antagonist 2-
AP5 and the non-competitive antagonist dizocilpine (MK-801) were used. 
2-AP5, as with some competitive antagonists (straight chain, piperidine and 
piperazine structures) displays the subunit potency NR2A > NR2B > 
NR2D > NR2C (Laurie & Seeburg, 1994). However, neither kynurenic 
acid, 2-AP5, dizocilpine nor PEAQX revealed a novel action of 
homoquinolinic acid on the fEPSP slope. Therefore, the novel binding site 
for homoquinolinic acid does not affect acutely recorded synaptic 
potentials in the hippocampus and homoquinolinic acid appears to be a 
selective agonist at NMDA receptors that include the NR2A subunit. 
Particularly when studied on fEPSPs, the paired-pulse paradigm represents 
a valuable means of assessing the actions of compounds on presynaptic 
terminals. The paired-pulse inhibition obtained at interpulse intervals of 
10ms results from the depletion of transmitter from presynaptic stores 
(Burke & Hablitz, 1994; Wilcox & Dichter, 1994; Hashimoto & Kano, 
1998), and is reduced by agents or procedures which decrease transmitter 
release. Paired-pulse facilitation, observed at longer interpulse intervals, is 
due to the residual intraterminal Ca2+ which increases transmitter release 
173 
(Hess et ai., 1987; Wu & Saggau, 1994; Debanne et aI., 1996; 
Kleschevnikov et ai., 1997). The modification of paired-pulse interactions 
by homoquinolinic acid and quinolinic acid suggests that at least part of its 
ability to depress the fEPSP slope is presynaptic in origin. Indeed, there is 
ample evidence corroborating the existence of presynaptic NMDA 
receptors in several regions of the brain (Berretta & Jones, 1996; Hamada 
et ai., 1998; Glitsch & Marty, 1999; Woodhall et ai., 2001), including the 
hippocampus (Breukel et ai., 1998). Alternatively, a retrograde signalling 
molecule released postsynaptically in response to depo1arisation by 
homoquinolinic acid may mediate this effect indirectly or other 
postsynaptic effects may confound the changes in PPD and PPF (Foster & 
Richardson, 1997). The possibility that adenosine released in response to 
neuronal depo1arisation could act as a retrograde inhibitor was investigated 
using the selective Al receptor antagonist DPCPX. However, DPCPX had 
no effect upon the magnitude of the depression caused by homoquinolinic 
acid or paired-pulse interactions suggesting that the presynaptic activity of 
homoquinolinic acid is not dependent upon the activation of presynaptic 
adenosine Al receptors. 
As previously seen with NMDA, Ro 25-6981 potentiated the responses to 
HQA and QA on fEPSP slope and altered paired-pulse interactions. One 
possibility for the potentiating effect of Ro 25-6981 is that it causes an 
increase in the release probability of glutamate from the presynaptic 
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boutons. This is unlikely as there is no effect of Ro 25-6981 on baseline 
ffiPSP or on comparable responses to AMP A and kainate. Another 
possibility is that Ro 25-6981 increases the local release of an endogenous 
NMDA agonist such as glycine, homocysteate, cysteine sulphinate or 
aspartate (Patneau & Mayer, 1990; Davanger et al., 1994). Whilst glycine 
has a high affinity and is thought to saturate NRIINR2B receptors, it has a 
lower affinity for NRIINR2A receptors, which under resting concentrations 
of glycine could be unsaturated and may be potentiated with rising glycine 
concentrations. 
CCMQ was not able to block the depression of ffiPSP slope at a similar 
concentration at which it displaced the binding of HQA in binding studies. 
Furthermore, the Ro 25-6981-enhanced response to HQA was similarly not 
blocked. This suggests that CCMQ is not acting as an antagonist in its 
ability to displace HQA from NR2A subunits in the previous studies. 
Considering the slight, yet significant, increases in ffiPSP slope elicited by 
CCMQ under the influence of Ro 25-6981 it is possible that CCMQ is a 
weak NR2A agonist. This will best be confirmed using recombinant 
NRIINR2A receptors expressed in Xenopus oocytes. Once this has been 
achieved, a study of structure-activity relationships could lead to more 
potent and selective NR2A agonists. 
The absence of effect of zinc as an NR2A antagonist may be due to the 
experimental conditions where the level of NR2A inhibition is already 
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saturated by the concentrations of zinc contaminating the ACSF. Also 
there may be physiological mechanisms that regulate zinc inhibition still 
active in the intact slice preparation, such as tyrosine kinase src 
phosphorylation and chelation of zinc by thiol-reducing agents (Paoletti et 
al., 1997; Arden et al., 1998; Zheng et al., 1998). In addition, differences 
between native heteromeric receptors and the recombinant receptors may 
weaken the effectiveness of zinc. Zinc is concentrated by certain neurones 
into synaptic vesicles and can be released in a Ca2+ -dependent manner at 
some synapses including the mossy fibre-CA3 pyramidal synapse 
(Dingledine et al., 1999). 
The effect of the NR2A antagonist PEAQX demonstrates that the NR2A 
subunit-containing NMDA receptors gate the currents involved in the 
depression of fEPSP slope and the associated paired pulse interactions. 
The enhancements of paired-pulse interactions are associated both with 
HQA alone and under the influence of Ro 25-6981, where the NR2B 
subunit is in both an activated and inhibited state. This suggests that the 
NR2B subunit cannot independently alter the presynaptic element 
suggested by paired-pulse results although it may be able to do so 
indirectly by its modulation of NR2A subunits, which alone seems to 
modulate directly the enhancement of paired-pulse interactions and the 
depression of the fEPSP slope. 
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Chapter 6. General Discussion 
Negative coupling of NR2B to NR2A subunit-containing 
receptors 
This study has suggested that acutely activated, tonically activated or 
constitutively active NR2B subunits maintain an inhibitory restraint upon 
the activation of the NR2A subunit-containing NMDA receptors by way of 
a protein phosphatase 2B (ca1cineurin) transduction step. The NR2A 
subunit-containing receptor seems to be the principal receptor involved in 
postsynaptic depolarisation and presynaptic alteration of release 
probability. The NR2B subunit has no observable function other than to 
gate the activity of the NR2A subunit-containing NMDA receptors. A 
recent report investigating the properties of NRllNR2BINR2D receptors 
expressed in newborn rat hippocampal granule cells has also observed 
evidence of negative coupling (Pina Crespo & Gibb, 2002). Additionally, 
NR3A subunits have been shown to negatively modulate NMDA receptors 
(Das et al., 1998). Although the effect ofRo 25-6981 is dependent on the 
presence of an NMDA receptor agonist to observe its effect, it is a 
persistent change in the weight of the synapse over a timescale reported to 
be associated with a potentiation of NMDA (Watt et al., 2004). 
Furthermore, it may involve co-incident pre- and postsynaptic activity 
suggestive of a Hebbian process. The NMDA receptor has a central role in 
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the induction of LTP and LTD, the negative coupling demonstrated in this 
study has significant implications for determining both the threshold for 
L TP and LTD induction and perhaps the magnitude of plasticity induced. 
The cellular mechanism by which this enhancement is produced is not 
entirely understood. Such an enhancement has very exciting implications 
for our understanding ofNMDA receptor physiology and pharmacology. 
Multimeric NMDA receptor composition 
Nicotinic acetylcholine receptors are pentamers, voltage-gated potassium 
channels are tetramers and gap junction proteins mediating coupling at 
electrical synapses are hexameric (or hexamonic). Glutamate receptors 
were often supposed to be pentamers because they, like the acetylcholine 
receptor are ligand gated. Equal evidence exists for both a tetrameric or a 
pentameric structure from receptor subunit studies (Behe et ai., 1995; 
Ferrer Montiel & Montal, 1996; Premkumar & Auerbach, 1997; Laube et 
ai., 1998; Mano & Teichberg, 1998; Rosenmund et ai., 1998). However, 
these studies are designed to identify the number of functional binding sites 
in a receptor but are based upon the assumption that each binding site in a 
receptor operates independently of other subunits. This study has 
suggested that there is a negative coupling between the NR2A and the 
NR2B receptor subunits and it has been reported by others of a negative 
coupling in receptors containing NR3A and NR2A subunits (Ciabarra et 
ai., 1995; Das et ai., 1998) and NR2B and NR2D subunits (Pina Crespo & 
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Gibb, 2002). This observation suggests that the analysis of dose-response 
curves (Laube et al., 1998) and patterns of main and sub-conductance states 
(Behe et al., 1995; Premkumar & Auerbach, 1997) may be more 
complicated and the heteromeric structure of the native NMDA receptor 
may have been miscalculated. 
Presynaptic NMDA receptors 
Demonstrating the role of presynaptic receptors definitively ideally 
requires the fulfilment of five criteria (McGehee & Role, 1996; 
MacDermott et al., 1999): 
1. Evidence for the presence of presynaptic receptors. 
2. Activation of these receptors exogenously produces the 
presynaptic effect that alters release probability (that mimics 
physiological control). 
3. Presence of an endogenous ligand at the synapse that can be 
released under physiological conditions for activation of the 
presynaptic receptor. 
4. Antagonists that block the presynaptic ionotropic receptors block 
synaptic plasticity. 
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5. Activation of the presynaptic receptor leads to the observed 
change in release through a characterised mechanism. 
In answer to these criteria: 
1. AMP A, kainate and metabotropic glutamate receptors have all been 
established as presynaptic autoreceptors in the hippocampus 
(Vazquez et al., 1994; Chittajallu et al., 1996; A1ici et al., 1997), 
modulating excitatory transmission by altering glutamate release 
probability. NMDA receptors have been amply demonstrated on the 
postsynaptic membrane (Petralia et al., 1994; Racca et al., 2000) and 
there is accumulating evidence demonstrating a presynaptic locus. 
Presynaptic NMDA autoreceptors have been reported in the 
cerebellum (Glitsch & Marty, 1999), spinal cord (Liu et aI., 1997), 
hippocampus (Breukel et al., 1998), suprachiasmatic nucleus 
(Hamada et aI., 1998) and entorhinal cortex (Berretta & Jones, 
1996). Furthermore, presynaptic NMDA receptors have been 
reported to be NR2B subunit-containing and tonically activated, 
causing an increase in glutamate release probability, dependent upon 
Ca2+ influx, in the entorhinal cortex (Woodhall et aI., 2001). 
Additionally, immunohistochemical studies have found evidence for 
presynaptic NMDA receptors (Liu et ai., 1994; Paquet & Smith, 
2000). 
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2. This report has suggested, through the changes observed in paired-
pulse interactions, that NMDA receptor activation by HQA, QA and 
NMDA generated an effect with a presynaptic element. However, 
whilst PPF and PPD are generally accepted to be presynaptic 
phenomenon, it does not follow that postsynaptic effects cannot 
influence their appearance in field recordings (Foster & Richardson, 
1997). 
3. The endogenous ligand at these synapses is glutamate, which could 
act under physiological conditions to activate a presynaptic receptor. 
Furthermore, this study has demonstrated this effect by using another 
endogenous ligand quinolinic acid. 
4. This investigation has demonstrated that both 2-AP5 and PEAQX 
can block NMDA-receptor dependent LTP. Furthermore, it has been 
reported recently that Ro 25-6981 is able to inhibit LTD (Sjostrom et 
aI., 2003; Liu et at., 2004; Massey et at., 2004) 
5. The inhibition of this effect by cyclosporin A, which modulates 
protein phosphatase 2B (ca1cineurin) activity, demonstrates a distinct 
and well-characterised signal transduction pathway. 
The lack of sufficiently compelling evidence on point 2 in this study means 
that there is not full qualification for a presynaptic NMDA receptor. 
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Therefore, the possible involvement of a postsynaptic receptor with a 
retrograde signalling mechanism must be considered. In NMDA receptor 
dependent synaptic plasticity, postsynaptically induced processes such as 
LTD and LTP are still able to trigger presynaptic changes through 
retrograde messengers such as nitric oxide activating PKG (Reyes Harde et 
al., 1999) and endocannibinoids acting upon CBl receptors (Cheval eyre & 
Castillo, 2003; Sjostrom et at., 2003) or release from other sources such as 
glia (Parpura et al., 1994). 
Whilst changes in paired-pulse interactions are widely regarded to be due 
to presynaptic alterations in release probability; when studied on ffiPSPs 
and especially where there are changes in the size of the postsynaptic 
potential in response to the test agents many factors affect them which can 
affect their interpretation. Including, changes in presynaptic release 
probability (Andreasen & Hablitz, 1994), activity of presynaptic 
autoreceptors on inhibitory or excitatory terminals (Davies et al., 1990; 
Stanford et al., 1995), modulation of postsynaptic conductances and the 
presence of GABA-ergic inhibition following the ffiPSP and the depression 
cause by NMDA agonist action (Duguid & Smart, 2004). 
Also, considering the intracellular data showing a purely postsynaptic 
manifestation of these effects a further study of the contribution of different 
NMDA subunits is required on clear presynaptic phenomenon such as 
spontaneous miniature EPSPs or by concurrently measuring by patch-
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clamp whole cell recording corresponding presynaptic and postsynaptic 
neurones. 
It is clear that NR2A and NR2B subunit-containing NMDA receptors are 
found postsynaptically, as NR1INR2A, NRIINR2B or NR1A1NR2A1NR2B 
heteromers, at the synaptic site whilst NR11NR2B receptors are found 
exclusively at the extrasynaptic site (Li et at., 1998; Stocca & Vicini, 1998; 
Tovar & Westbrook, 1999). A tonically activated state of the agonist-
preferring NR2B subunit-containing receptor could be achieved by being 
located near to the release site of glycine and glutamate on the presynaptic 
bouton. However, the NR2B subunit in both it's activated and inhibited 
state is associated with enhancements in paired-pulse inhibition whereas, 
only the blockade of the NR2A subunit prevents the enhancement of 
paired-pulse interactions. Alternatively, the NR2B subunit may be in a 
constitutively active state that is independent of agonist binding as has been 
observed with other receptors (Scheer & Cotecchia, 1997; Behan & 
Chalmers, 2001; Richard et at., 2001). Interestingly NR2B subunit-
containing receptors have a higher glutamate and glycine affinity, are less 
sensitive to tonic proton inhibition, and are insensitive to desensitisation, 
which suggests that they would be more sensitive detectors of glutamate 
than NR2A subunit-containing receptors, especially at extrasynaptic sites. 
Applications of HQA, QA and NMDA by themselves and under the 
influence of NR2B antagonism are associated with depressions of fEPSP 
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slope and increases in paired-pulse ratios. These are both blocked by 
PEAQX, the NR2A antagonist, suggesting that the presynaptic element 
may be NR2A subunit-mediated. It is difficult from the current study to 
make any definitive resolution of the receptor populations found pre- and 
postsynaptically or the subunit makeup of such receptors. 
It may be possible to investigate these further using single channel analysis 
of outside-out patches from these tissues. Using selective antagonists, it 
can be determined whether the negative coupling of NR2B upon NR2A is 
between subunits in a single heterotrimeric NR1INR2A1NR2B receptor 
(rather than between discrete heterodimeric NR11NR2A and NR1A1NR2B 
receptors). This may also address the location of these subunits at pre- or 
postsynaptic sites. There is evidence for the co-localisation of NR2A and 
NR2B subunits in the hippocampus, and specifically within the CA 1, CA2 
and CA3 regions (Fritschy et aI., 1998). 
Excitotoxicity 
This report has demonstrated that, far from being neuroprotective, Ro 25-
6981 actually precipitates an excitotoxic insult from otherwise benign, 
depolarising concentrations of NMDA and HQA. This observation is 
contradictory to prevIOUS reports of NR2B antagonists being 
neuroprotective in excitotoxic studies (Gotti et al., 1988; Fischer et al., 
1997; Lynch et al., 2001; Gill et al., 2002) but some reports have 
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corroborated this study (Zou & Crews, 2003). The age of tissue used in 
investigations could account for the reason for the difference in these 
results. In previous studies immature tissues were used whereas this study 
has used adult tissues in a well-proven experimental model of 
excitotoxicity (Schurr et aI., 1995). As mentioned in the introduction, the 
expression levels and distribution of NMDA subunits change dramatically 
during development, especially in respect of the NR2A and the NR2B 
subunits. This developmental change is responsible for the alteration in 
susceptibility of tissues to excitotoxicity and also to the induction of 
synaptic plasticity (Dudek & Bear, 1993; Liu et al., 1996). The use of 
immature tissues to investigate excitotoxicity is dictated to some extent by 
methodological constraints. The rationale for using these tissues in the 
investigation of stroke, which is an almost exclusive threat to the adult 
population, is difficult to justify, especially here, considering the disparity 
between these results. Additionally, the study of tissue from different areas 
of the brain and even different regions of the hippocampus will dictate the 
influence of NMDA receptors and the expression of different types and 
quantity of NR2 subunits. A recent study of cultured hippocampal 
neurones reported that the selective activation of synaptic NR2A subunit-
containing NMDA receptors is associated with the potent activation of 
cAMP response element binding protein (CREB) and subsequent brain-
derived neurotrophic factor (BDNF) gene expression. This leads to an anti-
apoptotic cell-signalling pathway. However, the activation of NR2B 
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sensitive extrasynaptic NMDA receptors by bath application of NMDA 
agonists or exposure to hypoxic/ischaemic conditions, which cause the 
reversal of glutamate transporters (Rossi et al., 2000), is associated with the 
Ca2+-dependent transient activation of CREB. This leads to a CREB shut-
off signal of the synaptic pro-survival pathway and leads to cell death 
(Hardingham et al., 2002). It can be concluded that exceSSIve 
overactivation of the NR2A-subunit associated channel could be directly 
responsible for the large Ca2+ influx that triggers excitotoxicity. The NR2B 
subunit acting to gate the activity of the NR2A subunit-containing receptor 
and when it is inhibited this restraint is lost. 
An obvious question anses as to whether there a correlation between 
decreased levels of NR2B subunit expression, mRNA levels and genetic 
expression in adult patients susceptible to stroke or in geriatric patients who 
have an age-related susceptibility to stroke and in other relevant disease 
states. Indeed, the NR2B subunit is already implicated in an impressive 
number of age related diseases and developmentally, the mRNA and the 
protein expression of the NR2B subunit decreases significantly between the 
ages of 3 and 30 months in mice (Magnusson, 2000; Magnusson et al., 
2002) which is similar to the decrease in the human hippocampus (Law et 
aI., 2003). It is possible to further develop this study by investigating the 
effect of selective subunit NMDA antagonists in hypoxia, ischaemia and 
seizure disorder, which are known to have NMDA receptor components. 
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The potential for the development of drugs to modulate this NR2B-NR2A 
interaction is very exciting. 
Phosphatase hypothesis 
This report has suggested that NR2B subunits maintain an inhibitory 
control over NR2A subunit-containing receptors. It could achieve this by 
being acutely activated, tonically activated or remaining constitutively 
active physiologically, maintaining the phosphorylation state of an 
unidentified protein. The superfusion of Ro 25-6981 blocks the NR2B 
subunit leading to the ca1cineurin-mediated dephosphorylation of an 
unknown protein residue resulting in the potentiation of NR2A subunit-
containing NMDA receptor responses. NR2 subunits are known to be 
highly phosphorylated under basal conditions whilst NR1 subunits are very 
weakly phosphorylated (Lau & Huganir, 1995; Hall & Soderling, 1997; 
Smart, 1997). Therefore, the dephosphorylation step described here may 
be acting directly upon either the NR2A or the NR2B subunit to produce 
the enhancement of responses to NMDA and HQA. However, it may also 
be acting on the NR1 subunit or associated proteins such as PSD-95 and 
SAP 102 or an unrelated and possibly novel site. Interestingly, there is 
strong evidence for a tyrosine residue that is phosphorylated and leads to 
potentiation of the NMDA receptor and is found on the NR2A or NR2B 
subunit-containing receptor, as seen with insulin potentiation and LTP 
(Chen & Leonard, 1996; Kohr & Seeburg, 1996; Rosenblum et al., 1996; 
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Smart, 1997; Zheng et at., 1998; Christie et at., 1999). The absence of 
effect of okadaic acid, a potent inhibitor of the serine/threonine protein 
phosphatases types 1 and 2A, rules out these serine residues being 
involved. The next step is to identify if there are changes in the levels of 
phosphorylation of these subunits. This can be achieved by a combination 
of immunoprecipitation using NR1, NR2A and NR2B subunit specific 
antibodies to these proteins, then immunoblotting with anti-
phosphotyrosine and anti-phosphoserine specific antibodies and estimating 
changes in levels of phosphorylation compared to controls with a 
chemiluminescent secondary antibody. There are many studies that 
correlate increases in phosphorylation with increases in receptor activity 
and that dephosphorylation is associates with reductions in receptor activity 
(Smart, 1997). However, it was found in this study that the activity of 
ca1cineurin, which de-phosphorylates is associated with the potentiation of 
responses to NMDA. This is blocked by Cyclosporin A, a phosphatase 
inhibitor. Many of the previous studies were carried out using immature 
tissue as with previous excitotoxicity reports as mentioned previously. In 
addition to the developmental switch of subunit expression (Tovar & 
Westbrook, 1999) the basal levels of phosphorylation of the adult NMDA 
receptor do not reach maturity until 3-4 weeks post-natally (Cudmore & 
Gurd, 1991). 
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Synaptic plasticity 
The entry of calcium into the neurone contributes ~ 16% of the NMDA 
receptor current but the subsequent activation of Ca2+ -dependent enzymes 
and signal transduction pathways induce potent effects (Schneggenburger 
et a!., 1993). Both LTP and LTD can be induced by NMDA receptor 
activation, resulting in an influx of Ca2+ that triggers plasticity. The 
relative level, kinetics and location of the Ca2+ influx determining whether 
L TP or LTD is induced; a large, fast, synaptic influx inducing L TP and a 
relatively modest, prolonged, extrasynaptic influx inducing LTD (Lisman, 
1989; Artola & Singer, 1993; Neveu & Zucker, 1996; Yang et a!., 1999; 
Cho et al., 2001; Liu et al., 2004; Massey et a!., 2004). The receptor 
kinetics of the NR2B subunit-containing receptor is relatively slower than 
the NR2A subunit-containing receptor resulting in calcium influxes that are 
consistent with LTD and LTP induction respectively (figure 61). This 
suggests that there is a role of NR2B in LTD that requires an NMDA-
mediated influx of Ca2+ consistent with the NR2B subunit-containing 
NMDA receptor kinetics. Indeed, it has recently been reported that 
neocortical LTD is inhibited by NR2B antagonists affecting presynaptic 
receptors (Sjostrom et aI., 2003), that LTD in the perirhinal cortex is 
inhibited by the NR2B antagonist Ro 25-6981 but not by the NR2A 
antagonist PEAQX (Massey, 2003; Massey et al., 2004) and that LTD in 
the hippocampus is NR2B dependent (Liu et al., 2004). The NR2A 
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subunit-containing receptor has kinetics consistent with those required for a 
large and rapid rise in intracellular calcium concentrations leading to L TP 
induction. During LFS protocols that induce LTD the NRIINR2B 
receptors make a larger contribution to the total charge transfer and Ca2+ 
influx whereas during HFS protocols that induce LTP the NRIINR2A 
mediates the greater total charge transfer and Ca2+ influx (Erreger et aI., 
2005). This study has demonstrated that the NR2A subunit is critically 
required in the induction of L TP. Furthermore, it is known that LTP 
requires protein kinase activation (Malenka et aI., 1989) while LTD 
requires protein phosphatase activation (Mulkey et aI., 1993; Mulkey et ai., 
1994). This study has also shown that the protein phosphatase 2B 
(calcineurin) inhibitor cyc1osporin A is able to prevent the effect of Ro 25-
6981. This is consistent with reports of calcineurin being critical in the 
induction of LTD (Mulkey et aI., 1994). This study cannot rule out the 
involvement of the NR2B subunit in Schaffer collateral-CAl LTP, 
especially considering the interaction of NR2B with the critical NR2A 
subunit-containing NMDA receptors described, the marginal reduction in 
L TP induced and the many reports implicating the NR2B subunit in L TP. 
This report has suggested that NR2B subunit-containing NMDA receptors, 
which have been reported to be tonically or constitutively active (Sah et ai., 
1989; Berretta & Jones, 1996; Breukel et ai., 1998; Woodhall et ai., 2001) 
and are critically involved in the induction of LTD (Sjostrom et aI., 2003), 
190 
negatively gate under physiological conditions the NR2A subunit-
containing NMDA receptor. It is widely reported and our studies have also 
found that successful NMDA dependent LTD induction is very difficult to 
achieve whilst L TP induction is relatively easy (Kemp & Bashir, 200 I; 
Massey et al., 2004). It could be that such tissues, rather than being in a 
resting state, are in a maximal LTD state and are therefore only able to be 
potentiated towards an L TP state from which level they can then be easily 
depotentiated. This could be explained by differential expression of NR2 
subunits in NMDA receptors. This study has not demonstrated that there is 
a way to increase the levels of the NR2B-mediated restraint and this may 
be because the level of restraint is saturated. A caveat to this link is the 
exclusivity to the NMDA receptor and the requirement of NMDA agonist 
to observe this phenomenon. The induction of LTP and LTD critically 
require the NR2A and NR2B subunits respectively but they are further 
associated with the trafficking of AMP A receptors to and from the 
postsynaptic membrane and an associated change in the synaptic weight of 
neuronal transmission independent of NMDA receptor agonists (Malinow 
& Malenka, 2002; Watt et a!., 2004). This is missing from the interaction 
this study has shown but if bridged might lead to the induction of L TP 
proper. 
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Donald Hebb's neurophysiological hypothesis states that' When an axon of 
cell A is near enough to excite a cell B and repeatedly or persistently takes 
part in firing it, some growth process or metabolic change takes place in 
one or both cells such that A's efficiency, as one of the cells firing B, is 
increased.' (Hebb, 1946). 
A modification of this hypothesis has led to the Bienenstock-Cooper-
Munro (BCM) theory of the sliding threshold of synaptic plasticity 
(Bienenstock et aI., 1982). It hypothesizes that active synapses grow 
stronger or weaker when postsynaptic activity exceeds or falls below a 
'modification threshold', 8m • Presynaptic activity triggers synaptic 
depression or potentiation depending on the concurrent level of 
postsynaptic activity. The history of integrated postsynaptic activity 
determines the threshold level at which plasticity is induced; the value of 
8m varies as a function of the history of integrated postsynaptic activity. As 
average activity falls or rises, so does the value of 8m • 
This hypothesis led to the observations in the visual cortex that experience 
drives NMDA receptor subunit switching from LTD-induction-preferring 
NRllNR2B heterodimeric to LTP induction-preferring NRlINR2BINR2A 
heterotrimeric receptors (Kirkwood et aI., 1996; Philpott et al., 2001). 
NR2A and NR2B subunit-containing receptors provide the biological basis 
for the BCM sliding threshold of synaptic plasticity. This model is further 
strengthened by the recent reports of NR2A and NR2B antagonist sensitive 
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induction of LTP and LTD respectively (Liu et at., 2004; Massey et at., 
2004; Mallon et at., 2005). The negative coupling of NR2B to NR2A 
subunit-containing receptors may represent a further mechanism for fine-
tuning the strength of NMDA mediated synaptic transmission and for 
maintaining a threshold for induction of synaptic plasticity that only 
requires changes in the NR2B subunit. Perhaps by lateral diffusion 
between synaptic and extrasynaptic sites, in agreement with recent studies 
where the NR2A subunit does not appear to be very mobile (Groc et at., 
2004; Triller & Choquet, 2005). Furthermore, as well as the induction 
threshold for LTP or LTD induction there is also the magnitude of change 
in strength elicited (Castellani et at., 2001). It was found in this study that 
whilst LTD could not be induced, the level of LTP that was reliably 
induced was of a particularly high magnitude. A level at which it was then 
possible to depotentiate from (data not shown). It may be that the 
experience-deprived environment the rats are familiar with, means that the 
biological basis for the sliding threshold is set such that they are in a 
maximal state of LTD and that only LTP can be induced. It has been 
reported that rats from enriched environments are more likely to exhibit 
LTD (T.V.P. Bliss, personal communication). The investigation of this 
could help to discover more about the biological basis for the magnitude of 
synaptic plasticity induced and the effects of environment (Castellani et at., 
2001). 
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Figure 61. Phosphatase hypothesis. 
This scheme summarises the intracellular transduction systems that account for 
the differing pharmacology and physiology of the NR2A and NR2B subunit-
containing receptors, the associated phosphoprotein steps and their influence 
over L TP and L TO. In brackets are the relevant antagonists (Mulkey et al., 
1994; Revest & Longstaff, 1998). 
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Appendix 1 
Methods 
Experiments were carried out by Professor T.W. Stone to further 
investigate the actions of Ro 25-6981 using intracellular recording 
techniques. 
Intracellular recordings were made using sharp glass microelectrodes (o.d. 
1.5mm) (Clark Electromedical, Harvard Instruments). These were pulled 
on a Narashige vertical puller in a manually controlled two-stage process to 
produce pipettes with a shank length of approximately 20mm. The 
electrodes were filled with 1M potassium acetate, yielding a resistance of 
80-l00MO when measured in the extracellular space of the brain slices via 
the Neurolog amplifier. Potentials were amplified by a Neurolog 102 DC 
amplifier or by an Axoclamp-2A operated in bridge balance mode, and 
filtered between DC and 20KHz. The electrode was advanced in 2.51lm 
steps using a remotely controlled World Precision Instruments motorised 
stepper. When a neurone was approached, indicated by a rise in electrical 
noise, a brief increase of electrode capacitance ('buzz') was induced in 
order to facilitate entry. Cells were allowed to recover from penetration for 
at least 10 minutes before examining them for electrical properties and 
stability. Neurones were then used for experimentation if they displayed a 
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stable resting potential (±10% over 20 minutes) greater than 60m V and a 
spike of at least 70m V in response to an intracellular depolarising current 
pulse. Current pulses (OJ-InA) were used to monitor membrane input 
resistance throughout the experiments. Records were calibrated using the 
amplifier's own calibration pulse (1 Om V), and were recorded directly onto 
a high frequency thermal chart recorder (Grass instruments Dash IV), 
although the filter settings were placed at DC to 10Hz to reduce interfering 
transients and action potentials. 
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Results 
NMDA 
Four neurones were tested with a combination ofNMDA and Ro 25-6981. 
In each case, NMDA was superfused at a concentration of 2.5uM for 10 
minutes, with 20 minutes between each application. At least two control 
applications were made. At this concentration, the cells showed little or no 
response, the two applications of NMDA immediately prior to Ro 25-6981 
yielding barely discernible depolarisations of 0.19±0.048, 0.26±0.059mV 
(n=4). Ten minutes after the second of these controls, superfusion of 
Ro 25-6981 (3uM) was commenced for 20 minutes. The next application 
of NMDA (parallel with the second 10 minutes of Ro 25-6981) produced a 
similarly weak effect (0.26±0.066m V). However, the next application, 
which was begun 20 minutes after ending the superfusion of Ro 25-6981, 
produced a substantial depolarisation (l0.67±1.25mV; p<O.OOOOl, n=4) 
(figures 62 and 63). This suggests that the negative coupling of NR2B to 
NR2A subunit-containing NMDA receptors is occurring at postsynaptic 
sites. 
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Figure 62. Intracellular recordings of NMDA responses and the effect of Ro 25-
6981 
Intracellular recordings from a pyramidal neurone of resting potential -74 mV, 
with input resistance monitored by hyperpolarising pulses of 0.3nA amplitude, 
300 ms duration every 20 s. Recordings are from one of six neurons tested 
with 2.5~M NMDA and 3~M Ro 25-6981. In panels a-c, NMDA was superfused 
alone at 2.5~M for ten minutes, with twenty minutes between each application. 
Ten minutes after record c, Ro 25-6981 (3~M) was applied for twenty minutes. 
The next application of NMDA (d) (parallel with the second ten minutes of Ro 
25-6981) still produced no clear response. The next application (e, twenty 
minutes after ending Ro 25-6981) indicates an increased frequency of 
excitatory synaptic potentials elicited by NMDA, while in panel (f), NMDA 
produced a substantial depolarisation with superimposed action potentials 
(truncated). 
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Figure 63. Intracellular recordings showing the effect of NMDA alone and after 
the application of Ro 25-6981. 
Intracellular recordings from a pyramidal neurone of resting potential -68 mV, 
with input resistance monitored by hyperpolarising pulses of 0.3nA amplitude, 
300 ms duration every 20 s. Recordings are from a second of the six neurons 
tested with 2.5~M NMDA and 3~M Ro 25-6981. NMDA was superfused alone 
at 2.5~M for ten minutes, with twenty minutes between three repeated 
applications (a). Ten minutes after record the third application had ended, Ro 
25-6981 (3~M) was applied for twenty minutes. The next application of NMDA 
(parallel with the second ten minutes of Ro 25-6981) still produced no clear 
response. The next application (twenty minutes after ending Ro 25-6981) 
indicated an increased frequency of excitatory synaptic potentials elicited by 
NMDA, while in panel b, a further application of NMDA (fifty minutes after 
ending Ro 25-6981) produced a substantial depolarisation with superimposed 
action potentials (truncated). 
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Appendix 2 
PEAQX is an NMDA receptor antagonists with a preference 
for the 1A12A, rather than 1A12B receptor composition. 
Y. P. Auberson*, S. Bischoff, K. Lingenhoehl, H. Neijt, M. F. Pozza, M. Schmutz 
PEAQX is a water-soluble quinoxalinedione with a high affinity for the glutamate-
binding site of NMDA receptors (eH]CGP39653 binding assay: IC50 = I1nM). At a 
concentration of 10 /-lM, PEAQX showed no additional activity in a battery of 68 
radio ligand binding assays for CNS receptors. 
In vitro, PEAQX possesses a 126-fold selectivity for the NMDA 1A12A over 1A12B 
receptor composition expressed in Xenopus oocytes (Figure 1, IC50 = 14nM and 
1800nM respectively). Experiments on embryonic cortical cells and on neocortical 
slices confirm these results on native receptors: Cultured embryonic cortical cells 
express NR2A subunits at a very low level, resulting in a low potency of PEAQX (IC5o 
= 1 /-lM). NR2A subunits are expressed to a much larger extent in adult slices, and the 
effect ofPEAQX is therefore stronger in this model (IC5o = 68nM). 
Figure 1: Effect ofPEAQX on NMDA-induced currents in Xenopus oocytes expressing human NMDAR 
1A12A or 1A12B. Structure of(lRS,l 'S)-PEAQX. 
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In vivo, PEAQX is a potent anticonvulsant in both DBAl2 mice (tonic convulsions: 
ED50 = 1.2 mg/kg, 1h i.p.) and in the mouse maximal electroshock test (ED50 = 5 mg/kg, 
1h i.p.), with a long duration of action (~24h). Anticonvulsant activity after intravenous 
administration indicates a rapid brain penetration. The side effect profile of PEAQX is 
clearly different from non-selective or NMDA 1A12B selective NMDA antagonists, as 
it causes no motor stimulation at anticonvulsant doses, does not disrupt the prepulse 
inhibition in the rat startle model, and does not substitute for PCP in rats trained in a 
two lever operant task. 
* K-136.6.82, Novartis PharmaAG, 4002 Basel, Switzerland. 
Tel. +41616968404, Fax +41616968676, yves.auberson@pharma.novartis.com 
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